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ABSTRACT 
The aims of the ,investigations presented in 
this thesis were to elucidate aspects of the immunology 
and pathogenesis of viral infections during pregnancy 
and to find whether cell-mediated immune responses in 
an infected mother have a deleterious effect on the 
continuation of the pregnancy. The laboratory mouse 
was chosen as an experimental animal because of its 
relative ease of breeding, storage and handling, the 
availability of adequate numbers of mice of different 
strains, and the ability to obtain pregnant mice at 
specified times of gestation. Model infections were 
established using 2 viruses, Ross River virus (RRV) and 
a strain of Semliki Forest virus (SFV), which are both 
lethal for neonatal but not adult mice. 
Initial investigations examined whether the 
non-specific immuno-suppressive mechanisms which have 
been postulated to prevent maternal rejection of her 
foetus also depress the mother's systemic anti-viral 
immunity. No evidence was obtained suggesting that the 
state of pregnancy per se is associated with a systemic 
depression of either the stimulation or expression of 
anti-viral immunity in the mother. On the contrary, 
certain maternal T-cell mediated immune responses 
appeared to be markedly enhanced following infection 
with SFV during pregnancy. This enhanced immune 
reactivity was detected in the spleen, as well as the 
lymph nodes which drain the uterus. It was therefore 
suggested that the mother was hyper-immunised by a 
large antigenic stimulus which probably originated 
from the infected placental and foetal tissue within 
the uterus. 
The effect on the pregnancy of maternal 
infection with either RRV or SFV was examined. 
Infection of 10 or 11-day pregnant mice with RRV 
always resulted in in utero death of a proportion of 
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the foetuses, with the others apparently unharmed. 
Abortion was not observed. Kowever, infection of 
pregnant mice at the same st~ge of gestation with SFV 
always resulted in abortion, which was preceded by 
uniform foetal infection. Maternal inoculation with 
eithBr RRV or SFV resulted in a haematogenous spread of 
virus throughout the maternal tissues, and the 
subsequent establishment of multiple, small infectious 
foci within the placental trophoblast. Foetal 
infection occurred at least 1 or 2 days after the 
initial detection of virus in the placenta. When foetal 
death occurred, it appeared to be a direct result of 
virus growth in foetal tissues. 
The placenta appeared to play an important 
role in the pathogenesis of the in utero infections. 
Foetal infection was aided by the apparent predilection 
of both viruses for placental tissue, and their 
subsequent growth to high titre in that organ. Further-
more, once the placental infection had become established, 
both viruses persisted at high titre in the trophoblast, 
even though they were cleared from the mothers' tissues.· 
It is possible that the expression of anti-viral 
immunity is in some way compromised in the micro-
environment of the placenta, and that trophoblast may 
therefore be an immunologically privileged site for 
virus replication. 
Investigations then concentrated on the 
reasons why some foetuses were spared from in utero 
infection with RRV, whereas others succumbed. The 
spared foetuses were found to be protected against 
experimental post-natal challenge with RRV, although 
the protection was only short-term. It was associated 
with the presence of anti-RRV activity in the IgG, but 
not IgM or IgA, fractions of their serum. These results 
indicated that the spared foetuses did not form an active 
immune response against in utero infection but were 
passively immunised by specific IgG derived from the 
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mother. It was proposed that the timing of foetal 
infection, relative to the timing of IgG transfer from 
the mother, may have been critical. When foetal 
infection occurred before antibody transfer, foetal 
death resulted, whereas when the maternal IgG was 
transferred to an uninfected foetus it neutralised all 
virus moving from the placental foci into the foetal 
circulation, and the foetus was spared. Anti-RRV IgG 
appeared to be unable to clear virus from already 
infected foetal tissue or the placental trophoblast. 
Results obtained with SFV indicated that the 
outcome of this infection during pregnancy may be 
dependent on a similar course of events except that, 
following maternal infection at gestation days 10 or 11, 
virus invariably grew through the placenta and infected 
all foetuses before the transfer of protective IgG from 
the mother. All foetuses therefore died in utero. 
The most severe effects on the pregnancy were 
produced by maternal infection with either RRV or SFV at 
gestation days 10 or 11. Infection at other stages of 
pregnancy resulted in a lower number of foetal deaths. 
It was suggested that these phenomena were linked to 
placental maturity rather than to any variation in 
foetal susceptibility throughout gestation. The less 
mature placenta may have been more refractory to virus 
growth, allowing more time for the passive protection of 
foetuses. Infection with SFV in early gestation also 
resulted in a lower incidence of abortion. It appeared 
that abortion was prevented when one or more foetuses 
within a pregnancy were spared from in utero infection. 
It was concluded that abortion was not triggered by virus-
induced maternal ill-health, placental malfunction or 
any T-cell mediated immuno-pathological phenomena but 
was dependent upon . the occurrence of uniform foetal 
infection. Possibly, uniform foetal infection may have 
resulted in an imbalance in hormone production by the 
foeto-placental unit which was not compatible with the 
normal progression of the pregnancy. 
Vlll 
Many of the conclusions from this thesis are 
related to the role of maternal IgG in the pre-natal 
passive protection of foetuses against in utero viral 
~ . 
infections. Experiments were also designed to investigate 
whether protection against RRV infection could be 
conferred post-natally, to neonatal mice. It was found 
that the suckling of colostrum and milk from a mother 
previously infected with RRV protected a susceptible 
neonate against homologous post-natal infection. As 
with the pre-natal transmission of antibody, these 
protected neonates only had detectable anti-RRV activity 
in the IgG fractions of their serum. No IgM or IgA was 
present, suggesting that all protective antibody was 
maternally derived. It was concluded that, in the mouse, 
all 4 IgG subclasses are selectively transferred from a 
mother to her offspring both pre-natally and post-natally. 
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CHAPTER 1 
GENERAL INTRODUCTION 
CHAPTER 1.1 
REVIEW: VIRAL INFECTIONS DURING PREGNANCY 
AND THEIR EFFECTS ON THE DEVELOPING FOETUS 
2 
3 
Viral infections of the mother during pregnancy 
are relatively common. In 1968, a survey of 30,059 human 
pregnancies in the United States indicated that 1600 of 
~ 
these women had a definite or presumed viral infection 
(other than the common cold) during their confinement. 
The actual attack rate would, in fact, be higher 
because no attempt was made to diagnose sub-clinical 
infections (Sever and White 1968). In general, the 
majority of these infections would be expected to have 
no adverse effects on foetal development. However, in 
some cases maternal viral infection can result in one 
or more of a range of syndromes in the foetus including 
in utero or post-natal death, abortion, congenital 
abnormalities, growth retardation or delayed post-natal 
disease (Mims 1968). 
As in any other related field, the actual 
effect produced is the result of the interaction between 
the host and the infecting organism. In pregnancy, 
however, two hosts, the mother and the foetus, are 
involved,each with a susceptibility which will vary 
according to genetic make-up, state of nutrition, stage 
of gestation, and anatomical factors such as the site 
and structure of the placental vessels, and the site of 
entry of infection (Alberman and Peckham 1977). 
In this Chapter it is intended to review 
aspects of the pathogenesis and immunology of a number 
of maternal infections which result in altered foetal 
development. Discussion will be limited to viral 
pathogens, howeve~ the importance of congenital 
infections with bacteria, protozoa and fungi in both 
human medicine (Gamsu 1977) and veterinary medicine 
(Morgan and Wrathall 1977) should not be underestimated. 
1.1.1 Congenital viral infections: extent of the 
problem 
The first association of foetal abnormalities 
with a virus infection during pregnancy was proposed by 
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Gregg in 1941 who noticed an unusually high incidence 
of congenital cataract in children who had been conceived 
during a rubella epidemic. Most of these babies were 
~ 
of small size and ill-nourished, and many had congenital 
heart defects. Since then numerous other viruses have 
been shown to cause intra-uterine infections in both 
humans and animals (Table 1.1). In humans, the two 
major causes of foetal infection and damage are rubella virus 
and cytomegalovirus (CMV). With rubella, the natural 
frequency of maternal infection in the United States 
prior to the availability of vaccines was estimated at 
8 cases per 10,000 pregnancies, rising to 220 cases per 
10,000 pregnancies in epidemics (Sever and White 1968). 
Because of the severity of foetal lesions following 
maternal rubella early in gestation it is usual practice 
for women with laboratory confirmation of infection 
during the first trimester to have their pregnancies 
terminated. In the United Kingdom this represents 
700 to 800 aborted pregnancies per year (Registrar 
General 1972-1973}. Even so, approximately 325 children 
were born with congenital rubella deformities in the 
U.K. during 1971-1972 (Meade and Atkinson 1977). 
CMV is probably the most common infectious 
agent to reach the foetus in humans but, unlike rubella, 
structural defects are rare with damage mainly being 
inflicted on formed organs, especially the central 
nervous system (CNS) (Alberman and Peckham 1977). The 
. 
incidence of congenital CMV infection in New York from 
1968 to 1971 was estimated to be between 60 and 150 per 
10,000 live births with significant CNS damage occurring 
in 10 % of these babies (Hanshaw 1971). In England and 
Wales, approximately 4000 CMV-infected babies were 
estimated to be born each year although , in conunon with 
the New York study , not all were expected to display 
overt disease (Lancet 1974). Approx imate l y 3% of 
susceptible women sero-conve rt during pre gnancy , indi-
cating a prima ry infection. Of the s e , the risk of 
foetal infection is a pproximate ly 50% (Stern and Tucker 
1973). However, because of the ma r k e d p ropensity of 
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Tab 1 e 1.1 Viruses associated with developmental defects in 
animals and mana 
Family 
Togaviridae 
Bunyaviridae 
Herpetoviridae 
Poxviridae 
Reoviridae 
Arenaviridae 
Parvoviridae 
Papovaviridae 
Retroviridae 
Virus 
.,, 
rubella 
hog cholera (vaccine strain) 
lactic dehydrogenase virus 
bovine diarrhoea-mucosal 
disease virus 
equine infectious arteritis 
Akabane 
Aino 
Rift Valley fever 
Nairobi sheep disease 
cytomegalovirus 
varicella-zoster 
virus of malignant catarrh 
feline herpesvirus 
equine rhinopneumonitis 
virus 
infectious bovine pneu-
monitis virus 
variola, vaccinia 
reovirus types land 2 
Colorado tick fever 
blue tongue (yaccine strain) 
lymphocytic choriomeningitis 
virus 
feline panleucopenia 
. . porcine parvovirus 
bovine parvovirus 
Kilhams rat virus 
aleutian disease virus 
minute virus 
polyoma virus 
stump-tailed monkey virus 
equine infectious anaemia 
Species Affected 
human 
pig 
mouse 
cow 
horse 
sheep, cattle 
cattle 
sheep 
sheep 
human 
pig 
guinea pig 
human 
wildebeest, cattle 
cat 
horse 
cattle 
human 
mouse 
mouse 
sheep 
mous2 
cat 
pig 
cattle 
rat 
mink 
mouse 
mouse 
stump-tailed 
monkey 
horse 
a. Modified from Mims (1981) and Parsonson et al. (1981). 
herpesviruses, including CMV, to reactivate in an 
immune host, the presence of maternal serum antibody 
does not necessarily mean that the foetus will be 
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~ protected (Stagno et al. 1973). A recent study of the 
incidence of congenital CMV infections in 3712 pregnant 
women indicated that primary and recurrent infections 
each resulted in 16 cases of congenital infection. 
However, the risk of clinically apparent disease in 
these children was much higher following a primary 
maternal infection (Stagno et al. 1982). This raises 
the possibility that vaccination against CMV, although 
fraught with difficulties, may be of value in decreasing 
the incidence of CMV-induced congenital defects (Medearis 
1982). It is of interest that the incidence of congenital 
CMV and other in utero infections may be higher in lower 
socio-economic groups and developing countries (Mata et 
al . 1977; Stagno et al. 1982). 
The cost to the community of human in utero 
infections is extremely difficult to quantify. Although 
the economic cost of short- and long-term social and 
medical care is probably not large in terms of the 
amount spent on public health as a whole (Meade and 
Atkinson 19771, the implications at the family and 
community levels of virus-induced foetal malformations 
and death may overwhelm any monetary considerations. 
The problems of viral infections during 
pregnancy are not confined to human medicine. Infer-
tility, reproductive failure, early embryonic death, 
neonatal death and abortion may result in considerable 
economic losses to the animal industry. The effect of 
these losses may be greatest in developing countries 
where expansion of the livestock population is frequently 
one of the principal aims (Ellis and Hugh-Jones 1977). 
Abortion rates in individual herds during epizootics 
may be as high as 50% with equine arteritis virus, 
60% with infectious bovine rhinotrache itis virus (IBRV), 
and 90% with equine herpesvirus type l (Morgan and 
Wrathall 1977). In fact, IBRV is one of the major 
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causes of bovine abortion in certain areas of the 
U.S.A. (Hubbert et al. 1973). In other areas of the 
world, including Australia, it has recently been 
recognized that Ak abane virus, an arthropod-borne 
agent, can cause extensive losses in both cattle and 
sheep, with over 50,000 calves estimated to have been 
lost in Japan between 1972 and 1980 (Bishop and Shope 
1980). 
1.1.2 The identification of potentially teratogenic 
and abortigenic viral agents 
The identification of viral agents which affect 
foetal development may present difficulties because of 
the often considerable delay between maternal infection 
and the subsequent discovery of abnormalities in the 
newborn. It is further complicated when the virus 
causes an inapparent infection in the mother, e.g., 
Akabane virus (Parsonson et al. 1981). It may also be 
difficult to recognize that a specific syndrome exists, 
especially if the rate of foetal infection or abnormal-
ities associated with a certain disease is low, or if 
immunity against the virus is widespread in females 
of reproductive age (Gershon 1975). When an infection 
results in early embryonic death in humans, the mother 
may not even realise she was pregnant (Siegel et al. 
1966). Likewise, virus-induced abortion may go un-
noticed in commercial herds of domestic animals (Winkler 
et al. 1975). Because of these problems, numerous human 
population surveys have been performed in an attempt to 
identify any cause-and-effect relationship between 
maternal illness during pregnancy and subsequent foetal 
death or abnormalities. These surveys have been either: 
a) Retrospective, where women who have given birth 
to babies with abnormaliti e s are questioned 
after the birth regardin g their health status 
throughout the pregnancy , e.g., Gre gg (1941); 
or 
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b) Prospective, where a group of pregnant subjects 
are selected early in pregnancy and monitored 
for infections throughout confinement. A 
correlation is then sought between the incidence 
of any foetal abnormalities and the observed 
infections, e.g., Siegel et al. ll966}. 
The value of these types of surveys is, however, 
dependent upon a number of points. Firstly, considerable 
care must be taken to ensure that correct, matched 
controls are used, especially if the test group has been 
selected in any way (Siegel and Fuerst 1966; Siegel et al. 
1966). Secondly, sensitive and accurate diagnostic 
tests should be used to confirm the nature of any 
infections, and reliance should not be placed on the 
interpretation of clinical signs lSever and White 1968). 
Finally, care should also be taken in the interpretation 
of the results. For instance, Leck (1963}, in a review 
of the literature suggesting that influenza caused 
foetal defects, doubted that there was a cause-and-
effect relation because the defects observed in the 
offspring of women who contracted influenza during 
pregnancy were representative of those expected to occur 
in the general population and did not constitute a 
specific syndrome. Furthermore, malformations were 
unexpectedly observed in the offspring of women who 
contracted influenza after foetal organogenesis was 
complete. 
It is generally agreed that prospective 
surveys are more accurate than retrospective surveys. 
The latter are likely to give a misleading estimate of 
the degree of risk because the abnormality being surveyed 
has already been selected before enquiry regarding the 
pregnancy. Furthermore, the mother's recollection of 
her health ard the timing of illnesses with regard to 
the stage of gestation may be faulty or influenced 
because she has given birth to an abnormal child 
(Logan 1951). 
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Effective prospective surveys may be protracted 
because the frequency of viral disease is usually low 
in women of child-bearing age, with the result that 
test and control groups may be difficult to obtain 
(Siegel et al. 1966). Furthermore, accurate information 
regarding the consequences of intra-uterine viral 
infections may not be available until years after birth. 
In congenital CMV infection which is inapparent at 
birth, some cases of hearing loss, along with a trend 
towards subnormal intelligence levels, may only be 
observed in later childhood (Reynolds et al. 1974). 
Likewise, in congenital rubella syndrome,ocular, 
auditory and CNS anomalies may only be apparent years 
after birth (Jackson and Fisch 1958; Hardy et al. 1969; 
Menser and Forrest 1974). This necessitates thorough 
and long-term follow-ups of all subjects. 
Thus, although a survey may provide a useful 
indication of the aetiologic role of certain viruses in 
foetal teratogenesis, the evidence is only indirect and 
should be backed up by serology and attempts at viru? 
isolation (Parsonson et al. 1981). The demonstration 
of pre-colostral specific IgM in human babies and/or 
IgG in the offspring of certain domestic animals may 
be considered as diagnostic of intra-uterine infection 
because trans-placental transfer of significant amounts 
of the maternal immunoglobulin does not occur (Miller 
1966; Stiehm et al. 1966; Morgan and Wrathall 1977). 
Intra-uterine infection of unknown aetiology may also 
be suspected in humans if the total foetal serum IgM 
concentration is elevated (Blattner 1974). The 
presence of specific foetal immunoglobulin is, however, 
dependent upon both the immunological maturity of the 
foetus at the time of infection (Silverstein et al. 1963), 
and, in a lethal infection, the foetus having sufficient 
time to produce antibody (Kendrick and Osburn 1973). 
Furthermore, certain viru.ses induce immunological 
tolerance in the foetus and no antibody is produced 
even though there may be a persistent viraemia (Plateau 
et al. 1980). Isolation of a virus from an affected 
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foetus or newborn provides excellent diagnostic evidence, 
however this may not always be possible because of 
autolysis or the presence of neutralising antibodies 
(Morgan and Wrathall 1977) ~ The value of attempting 
virus isolations from pathological material is 
illustrated by a recent report of the first recorded 
isolation of mumps virus from a 10 week human foetus 
which was aborted 4 days after the onset of clinical 
mumps in the mother (Kurtz et al. 1982). This appears 
to support results obtained 16 years previously from a 
survey that concluded that mumps may be a significant 
cause of early foetal death (Siegel et al. 1966). 
If virus isolation has been achieved, confir-
mation of its role in foetal infections is facilitated 
in veterinary medicine where it can be experimentally 
inoculated either peripherally into the mother or 
directly into the foetus in utero (Parsonson et al. 1981). 
For ethical reasons, this is not usually possible in 
humans although women certified for legal abortion have 
been infected with live rubella vaccine virus in an 
investigation of its safety (Vaheri et al. 1972}. 
1.1.3 Routes of virus entry into the foetus 
Foetal infection is achieved via a number of 
routes (Mims 1968; Plotkin 1975; Fox 1977). The major 
ones are: 
a) Via the germ line. The most effective route 
of vertical transmission is probably via integration 
of viral nucleic acid into the host germ line. 
Viruses that utilise this method must: 1) be non-
cytopathic; 2) not interfere with fertilisation 
or embryogenesis; 3) be able to maintain infection 
in rapidly dividing cells; 4) avoid host immune 
responses (Mims 1981). Oncoviruses provide a good 
example of vertical transmission by this method and 
utilise a reverse transcriptase to integrate their 
genetic information into the host genome (Jarrett 1977). 
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When germ line cells are infected the viral genome 
is transmitted to embryo cells and perpetuated in 
all subsequent offspring. These viruses have been 
detected in numerous species including mice, cattle, 
cats, chicken and the baboon (Gross 1951; Bentvelzen 
et al. 1970; Kalter et al. 1973; Levy 1973; Jarrett 
19 7 7; Mims 19 8l) , and may cause leukaemi,a or tumours 
in adult life (Gross 1951; Jarrett 1977; Mims 1981). 
Infection of the germinal epithelium or 
unfertilised egg without integration of viral nucleic 
acid into the host genome may also occur, especially 
if there is a persistent infection of maternal 
tissues accompanied by immune tolerance, e.g., 
lymphocytic choriomeningitis virus (LCMV) in mice 
(_Mims l968; Plotkin 1975}. 
Mims (19681 and Fox (1977) also suggest 
that another possible, but unproven, method of 
vertical virus transmission via the germ line is 
through a provirus in the sperm nucleus. 
b) "Ascending" infection. This is where the 
infection ascends into the amniotic sac from the 
vagina or cervix. This type of infection is 
usually peri-natal and often occurs after 
membrane rupture (Mims 1968; Plotkin l975). 
Most cases of ascending infection are caused by 
bacteria but a few are fungal in origin (Fox 1977). 
With viruses, ascending infection may be important 
in peri-natal intra-uterine infections with herpes 
simplex virus (HSV} (Nahmias et al. 1971; l975), 
and has also been postulated to be responsible for 
a proportion of foetal infections with rubella 
(Seppala and Vaheri 1974). 
As noted previously in Section 1.1.1, latent 
herpesvirus infections are commonly subject to 
recrudescences (Weller 1971). Activation of a 
latent CMV infection, with accompanying shedding 
of virus from the cervix, often occurs during 
pregnancy (Montgomery et al. 1972). It is there-
fore possible that when intra-uterine infection 
occurs following CMV reactivation in women who 
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have pre-existing serum antibody (Stagno et aL 1982), 
the route of infection is probably ascending rather 
than haematogenous (Lowrie et al. 1977). 
Ascending infections may also occur when 
viruses are present in semen (Mims 1981). It is 
possible that this occurs in border disease in sheep 
where the virus has been transmitted by semen from 
infected rams to susceptible ewes (Gardiner and 
Barlow 1981). Furthermore, in humans, CMV may be 
persistently shed in semen for up to 14 months 
after infection, suggesting the possibility that 
some intra-uterine infections by this virus may 
be sexually transmitted (Lang et al. 1974; Embil 
et al. 19 8 2) . 
c) Via the chorioallantoic placenta. The 
chorioallantoic placenta is found in all eutherian 
mammals although its structure and the number of 
cell layers separating maternal and foetal 
circulations depend upon both the species of 
animal and the stage of gestation (Enders 1965; 
Mims 1968). In both humans and rodents this placenta 
is of the haemochorial type where foetally-derived 
trophoblast tissue is in intimate contact with the 
maternal blood (Enders 1965; Pijnenborg et al. 1981). 
Viruses which cause in utero infections often have 
a predilection for the chorioallantoic placenta 
which becomes infected after a haematogenous 
spread of virus from the site of infection in the 
mother (Fox 1977). The release of infectious 
progeny virus from the placental focus of 
infection then results · in foetal infection. A 
direct passage of virus in maternal leukocytes 
or erythrocytes across the placenta may also 
occur (Catalano and Sever 1971; Lowrie et al. 1977), 
although there is little direct evidence that 
this constitutes an important mechanism of foetal 
infection. The possibility of a direct leakage of 
virus from the maternal to the foetal circulation 
must also be considered because of the results of 
Uhr et al. (1963) who found that bacteriophage 
crossed the guinea-pig placenta when high 
concentrations (10 7 phage/ml) were present in 
maternal serum. 
Other possible routes of virus entry into 
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the foetus are via the endometrium, yolk sac, fallopian 
tube, and surgical procedures such as amniocentesis 
or intra-uterine transfusions (Mims 1968; Plotkin 1975; 
Fox 1977) . However, infection via these routes rarely, 
if ever, occurs. 
1 . 1 . 4 The role of the placenta as a barrier to 
infection. 
Al though the placenta is often considered as 
a total barrier to the free passage of organisms from 
the maternal circulation to the foetus, Fox (1977) 
suggested that at best it can only physically delay 
foetal infection. Nevertheless, virus has been 
isolated from placental tissue in the absence of 
foetal infection in human rubella (Alford et al. 1964) 
and CMV infections (Hayes and Gibas 1971), as well as 
in animal infections with LCMV (Mims 1968) ,CMV 
(Johnson 1969) and IBRV (Kendrick et al. 1971; Kendrick 
1973). It is possible that in these examples the 
foetus is resistant to infection, although this can 
be tested, at least in animals, by direct in utero 
inoculation of the agent. 
Placen tal infection without foetal infection 
does not necessarily spare the foetus. Foetal death 
may occur as a direct consequence of virus-induced 
changes in the placenta and placental circulation 
involving vasoconstriction, congestion or haemmorrhage 
(Mims 1976b). This may be rare, however, because, 
although a number of viruses do cause focal villous 
inflammation in humans, the placenta has a large 
functional reserve capacity and is unlikely to be 
compromised in its efficiency (Fox 1977; 1981). 
Infection of mice with murine CMV is an example where 
foetal death without infection is common and appears 
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to be associated with virus replication in the placenta 
(Johnson 1969). However, the possibility that 
infection causes inapparent changes in the mother which 
are incompatible with foetal life must also be 
considered. 
1.1.5 The expression of anti-viral immune responses 
in the placenta. 
Johnson (1969) speculated that intrinsic 
placental antibody formation as well as interferon 
production by the trophoblast may be responsible for 
the failure of murine CMV to cross from the placenta 
to the foetus. It seems likely, however, that specific 
placental anti-viral immune mechanisms such as antibody 
production, if present, would only develop at the same 
rate as in the foetus and this, in turn, depends upon 
the species in question. In the mouse, the developing 
foetus appears to be immunologically incompetent 
(Silverstein 19 72), and the full functional expression 
of antibody and cell-mediated immune responses may not 
be gained until after birth (Makinodan and Peterson 1962; 
Dalmasso et al. 1963; Chiscon and Golub 1972). On the 
other hand, interferon may be important in limiting 
trans-placental virus spread (Fox 1977). Interferon 
is produced by foetal and placental tissue in a number 
of species (Isaacs and Baron 1960; Banatvala et al. 1971), 
and progressively concentrates in the mouse placenta 
throughout pregnancy (Fowler et al. 1980). It has been 
suggested that the reason why Japanese strains of 
rubella do not appear to cross the human placenta as 
often as other strains (Kono et al. 1969) is that the 
Japanese strains are much better inducers of interferon 
15 
in placental tissue (Banatvala et al. 1971; Potter 
et al. 1973). An alternative explanation, however, 
is that the Japanese race lacks certain HLA antigens 
which may determine susceptibility to rubella infection 
(Honeyman et al. 1975). 
In certain species, the mother may also 
contribute to the level of anti-viral immunity in the 
foeto-placental unit by the passive transfer of 
certain antibody classes (Miller 1966; Stiehm et al. 
1966; Morgan and Wrathall 1977; see also Chapter 1.3). 
However, it seems likely that the expression of 
maternal cell-mediated immune responses may be restricted 
or inhibited in the placenta. Numerous mechanisms have 
been postulated to explain why an allogeneic foetus is 
not rejected as foreign by the mother's immune system 
(reviewed in Chapter 1.2), and it is possible that 
viruses able to infect the placenta may utilise these 
same mechanisms to evade the maternal immune response 
and set up a persistent placental infection. This may 
be expected to facilitate foetal infection. Thus, in 
some respects, the placenta may be an immunologically 
"privileged" site for virus replication. 
1.1.6 Sequelae of virus infections in pregnancy 
1.1.6.1 Congenital abnormalities 
Virtually all congenital malformations of 
infective origin are caused by viruses because other 
organisms such as bacteria tend to release toxins 
resulting in extensive tissue damage with subsequent 
foetal death (Mims 1976b). During the embryonic period, 
which is characterised by cellular differentiation and 
early organ formation, exposure to teratogens is more 
likely to produce structural abnormalities, whereas 
exposure during the foetal period, which is characterised 
by growth and functional maturation, is more likely to 
cause disturbances in these developmental processes 
(Morgan and Wrathall 1977). This is exemplified in 
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human rubella where the risk of congenital malformation 
is dependent upon the stage of pregnancy at which 
infection occurs. Maternal infection during the first 
trimester represents the greatest risk to the foetus 
(Dudgeon 1969), with malformations of the heart, ear, 
eye and brain common (Banatvala 1977). However, in 
utero infection with rubella can occur at any stage 
of gestation (Cradock-Watson et al. 1980). Children 
from mothers infected during the second trimester may 
have more subtle disease manifestations such as impaired 
hearing and mental development which are not apparent at 
birth (Hardy et al. l969}. This is considered to be a 
consequence of the establishment of a chronic infection 
rather than a direct teratogenic effect on organ 
development. In vitro studies on the mechanisms of the 
rubella-induced teratogenic effects indicate that the 
virus causes chromosomal damage, a decreased mitotic 
rate and a reduced cell life (Plotkin et al. 1965; 
Rawls and Melnick 1966; Hoskins and Plotkin 1967; 
Plotkin and Vaheri 1967)_. Thus, the low birthweight 
often observed in infants with congenital rubella may 
be due to a decreased number of body cells and altered 
RNA and protein synthesis (Naeye and Blanc 1965; Hill 
et al. l970). Virus replication in foetal endothelial 
cells can result in areas of necrosis in affected 
tissues which may also contribute to the disease 
pathogenesis (Tondury and Smith 19661. 
A variation in the foetal susceptibility to 
virus damage at different stages of gestation is not 
unique to rubella. In other diseases, the specific 
target organs or cells may only be present or susceptible 
during a brief period of pregnancy. For example, when 
live bluetongue virus vaccine (BTVV) is given to pregnant 
ewes between gestation days 50 to 58 the foetuses 
develop a severe necrotising encephalopathy which 
presents at birth as hydranencephaly. Infection at 70 
to 78 days of gestation results in a multifocal enceph-
alitis and vacuolation of white matter which presents 
at birth as porencephalic cysts. However, if the vaccine 
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is given after 100 days of gestation only a mild focal 
encephalitis with no pathologic sequelae except glial 
nodules is observed (Osburn et al. 1971a}. Two factors 
were thought to account for this marked variation in 
... 
susceptibility of the foetal sheep to BTVV: 
a) The predilection of the virus for nervous 
tissue in the young foetal lamb may be due 
to a selective vulnerability of undifferen-
tiated neural cells to the infection. 
Increased resistance of foetal cells to 
infection appears to be associated with 
tissue differentiation and maturation. 
b) The late maturation of immune competence 
in the foetal lamb (specific serum-neutralising 
antibodies against BTVV may not be induced 
until after 122 days of gestation) allows 
infection prior to this time to proceed 
unimpaired (Osburn et al. 197lbl. 
A similar situation may be involved in the 
pathogenesis of Akabane virus infection of foetal sheep 
where abnormalities are only observed when pregnant 
ewes are infected between 30 and 36 days of gestation, 
even though there is serological evidence of foetal 
infection after maternal inoculation at other stages of 
pregnancy (Parsonson et al. 1977}. 
The deleterious effects of virus infections 
are not always limited to early gestation foetuses ·. 
Pathology associated with feline panleukopenia virus 
is most severe when foetuses are infected late in 
gestation, with the greatest destruction occurring in -
the cerebellum which undergoes growth activity at this 
time and in the neonatal period (Kilham et al. 1967). 
Furthermore, some viruses -may persist in foetal cells 
in latent form doing little or no damage until the 
susceptible period of development occurs when their 
teratogenic effect will be expressed. This has been 
suggested to occur with certain strains of swine fever virus 
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in pigs (Morgan and Wrathall 1977). 
1.1.6.2 Foetal death 
Foetal death tends to result from infections 
with highly cytolytic viruses that cross the placenta. 
When infection occurs in early gestation the dead 
embryo may be resorbed whereas later in gestation, 
after skeletal calcification has occurred, resorption 
may be incomplete with resultant mummification and 
abortion (Taylor-Robinson 1977). In polytocous species, 
abortion does not usually occur unless all foetuses die 
(Arthur 1975), presumably because only one viable foetus 
is required to maintain the hormonal balance necessary 
for the continuation of the pregnancy. Numerous viruses 
have been demonstrated or are suspected to cause foetal 
death. In humans these include: rubella, where foetal 
death occurs in approximately 50% of all cases when the 
mother contracts the disease in the first 8 weeks of 
gestation, and in approximately 20% of all cases during 
the third month (Siegel and Greenberg 1960); mumps, 
which is associated with a 32% foetal death rate if 
contracted during the first trimester (Siegel et al. 
1966); HSV, which has a high abortion rate associated 
with primary genital lesions during the first 20 weeks 
of gestation (~ahmias et al. 1971; Florman et al. 1973); 
and smallpox which, although not a health problem today, 
is included because it has caused an extremely high 
rate of foetal death and abortion in previous epidemics. 
In an Indian study, 72% of women who contracted small-
pox in the first 25 weeks of gestation had foetal loss. 
This decreased to a 39% loss when the disease was 
contracted during the 25th to 36th week of gestation. 
There was a 10 % incidence of stillbirth in those cases 
admitted at full term (Rao 1972). 
Some viruses kno"wn to cause a significant 
amount of foetal wastage in animals are: IBRV which, in 
cattle, frequently causes abortion (Kendrick and Straub 
1967); swine fever virus which causes an acute disease 
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in pigs and, depending upon the virulence of the 
infecting strain, can result in abortion and malformations 
(Morgan and Wrathall 1977); Akabane virus which, as 
previously noted, caused the loss of over 50,000 calves 
in Japan between 1972 and 1980 (Bishop and Shope 1980); 
bovine viral diarrhoea - mucosal disease virus which 
causes foetal death in both cattle (Done et al. 1980) 
and sheep (Parsonson et al. 1979). It has been suggested 
that the latter virus may be the most important pathogen 
of the bovine foetus in Great Britain (Done et al. 1980). 
Although the usual cause of foetal death is 
viral replication within foetal tissues, it may result 
from a disturbance in placental function. Viral 
infections may also cause a variety of disturbances in 
maternal health including hyperthermia, hypoxia, bio-
chemical imbalance or a nutritional disorder, any one 
of which may result in a detrimental effect on the foetus 
(Alberman and Peckham 19771. An elegant example of the 
influence of maternal health on foetal well-being is 
provided by the infection of pregnant mice with 
coxsackievirus B3 which leads to severe pancreatic 
acinar atrophy and hepatitis in the mother, and death 
or retarded development in the foetuses. It was 
suggested that the infected mothers may have had a 
dietary insufficiency attributable to an inability to 
break down and digest protein in their diet (Lansdown 
and Coid 1974), and this was supported when a dietary 
supplement of casein hydrolysate including free amino 
acids and simple peptides corrected the condition and 
allowed the pregnancy to proceed normally (Lansdown 1975). 
1.1.6.3 Delayed post-natal disease in the progeny 
In section 1.1.3 it was noted that oncoviruses 
are transmitted vertically by the germ line and may 
cause tumours or leukaemia in adult life. Association 
between infection in pregnancy and subsequent malignant 
disease has also been suggested for a number of other 
viruses including influenza, varicella and possibly 
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rubella (Fedrick and Alberman 1972; Blithel et al. 1973). 
Conversely, Leck and Steward (l972) found no such 
association with influenza. Although there is over-
whelming evidence that oncoviruses are able to 
initiate delayed neoplastic disease in the offspring, 
the evidence for the other viruses is not as strong, 
mainly because the surveys on which the statistical 
evaluations were performed may have been inadequate 
in a number of respects (Leck 1963; Blot et al. 1980). 
Other, non-malignant, examples of delayed post-
natal disease in the progeny of mothers infected during 
pregnancy include reovirus type 2 infection in mice, 
where decreased activity and growth retardation occur 
in some progeny between 15 and 36 days of life (Hashimi 
et al. 19661, and human rubella, where a chronic, 
progressive panencephalitis may be an infrequent 
complication in infants with congenital rubella 
syndrome (Weil et al. 1975). 
1.1.6.4 Virus persistence in the progeny 
Burnet and Fenner (1949) postulated that at 
some stage of embryogenesis the foetus develops a 
recognition mechanism when all antigens present are 
acknowledged as self antigens and are unable to 
thereafter stimulate an immune response in that host. 
In accord with this, viruses which infect a foetus at 
an early stage of development and do not prejudice its 
pre- or post-natal survival should also be recognized 
as self. This may lead to the establishment of a 
persistent infection, although the level of this persis-
tence may be influenced by maternal antibodies acquired 
trans-placentally or via colostrum. There are, in fact, 
numerous reports of virus persistence for weeks, months 
or even years following in utero infections with such 
agents as swine fever in pigs (Huck and Aston 1964), 
human rubella (Banatvala et al. 1965); reovirus type 2 
in mice (Hashimi et al. 1966), feline panleukopenia 
virus (Kilham et al. 1967), LCMV in mice (Skinner and 
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Knight l97l), human CMV (Stagno et al. l975), 
aleutian disease virus in mink (Porter et al. l977), 
bluetongue virus in sheep (Gibbs et al. 1979), 
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border disease in sheep (Barlow et al. 1980), hog 
cholera in pigs (Plateau et al. 1980) and bluetongue 
virus in North American elk (Stott et al. 1982). 
Such persistence may aid the spread of disease to 
other susceptible humans or animals (Buck and Aston 
1964; Banatvala et al. 1965; Skinner and Knight 1971; 
Plateau et al. 1980), and may allow "overwintering" 
of arthropod-borne diseases (Gibbs et al. 1979; Stott 
et al. 1982}. There seems to be two mechanisms 
involved in this virus persistence. Firstly, 
immunological tolerance, as assessed by the lack of 
a specific antibody response of the host to the 
virus, and as predicted by Burnet and Fenner (1949), 
may occur (Hashimi et al. l966; Skinner and Knight 
1971; Porter et al. 1977; Barlow et al. 1980; Plateau 
et al. 1980; Stott et al. 1982). Secondly, although 
the foetus may recognize the viral antigen as 
foreign, its immune response may be defective in 
some way and unable to clear the infection. For 
example, almost all children severely affected with 
congenital rubella syndrome excrete virus at birth and 
some may continue to excrete virus for months there-
after (Banatvala et al. 1965). This is not due to 
immunological tolerance because neutralising IgM 
antibodies are present (Alford 1965). However, 
when the immune responses of these children are 
more closely examined, defects in both humoral and 
cell-mediated anti-viral immunity may be observed 
(Soothill et al. 1966; Fuccillo et al. 1974). 
Whether these defects in the affected child's immune 
response precipitate virus persistence or occur as 
a consequence of it is not clear. 
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1 . 1 . 7 Immuno-therapy against congenital virus 
diseases 
1.1 . 7.1 Prophylactic immuno-therapy 
A good example of the successful use of immuno-
prophylactic measures to decrease the incidence of virus-
induced congenital abnormalities is provided by the human 
rubella vaccination programme. Tobin et al. (1977) noted 
that prevention of the birth of rubella damaged children 
can be accomplished in three ways: 
1) By identifying those pregnancies at risk and 
terminating them. 
2) By inducing immunity with live vaccine in 
women before pregnancy. 
3) By mass vaccination of school children to 
reduce the level of natural infection circulating 
in the community. 
Obviously , vaccination prograw~es are more socially 
acceptable than the first alternative! In the United 
States a live rubella vaccine became available in 1969, 
and in the first 5 years of use 5.5Xl0 7 doses were 
dispensed (Krugman and Katz 1974). Initial control 
measures were aimed at pre-school and young school-age 
children in order to decrease the overall number of 
rubella cases in the community. Vaccination of 
susceptible post-pubertal females was given a lower 
priority . Although this did result ina significant 
decrease in the incidence of rubella in the total 
population, and an initial decrease in the incidence 
of congenital rubella syndrome (CRS) (Krugman and Katz 
1974), the overall incidence of CRS has not declined in 
recent years (Orenstein and Greaves 1982). A change in 
vaccination strategy was therefore made in the mid-to-
late 1970s with greater emphasis being placed on 
vaccination of susceptible females of childbearing age. 
Orenstein and Greaves (1982) suggested that this has 
been only partly successful, however, because of: 
a) inadequate education ~of the general population; 
bL insufficient input by physicians and health 
workers into educationandvaccination of 
susceptible people. 
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Furthermore, they considered that possibly the only way 
to further decrease the incidence of CRS was to make 
vaccination compulsory for all students from kindergarten 
to 12th grade, as well as in all other institutions where 
young adults congregate. 
Although the vaccine strains in current usage (HPV77, 
Cendehill and RA27/3L are effective, they may not induce 
as high a level of immunity as the wild-type virus. 
There are both qualitative and quantitative differences 
in the antibody responses to rubella vaccination compared 
to the natural disease (Ogra et al. 1971; Al-Nakib et al. 
1975). Furthermore, natural reinfection may be more 
common in vaccinated people because of lower antibody 
levels (Lancet 1973). A recent study also indicated 
that vaccine-induced immunity may not be as long lasting 
as that induced by natural disease. Over 90% of 13 to 
14 year old school girls had detectable anti-rubella 
antibodies 7 years after vaccination with RA27/3 or 
Cendehill, although 13 to 14% had only low titres. 
After natural infection, however, 98.1% of girls were 
immune and only 4.5% had low antibody titres (Zealley 
and Edmond 1982). This study also illustrated that a 
proportion of both vaccinated and naturally infected 
people have no detectable antibody to rubella. Whether 
this is because sero-conversion never occurred (Menser 
and Forrest 1975) or antibody has just disappeared is 
not clear. 
A maJor problem with the use of live rubella vaccines 
is the possibility of accidental vaccination during 
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pregnancy, especially in early pregnancy when the mother 
may not be aware of her condition. This has been raised 
as an objection to the widespread and indiscriminate 
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vaccination of all post-pubertal females (Orenstein and 
Greaves 1982). There are reports of the isolation of 
virus from the placenta and occasionally the foetus 
after therapeutic abortion of initially sero-negative 
pregnant women who were vaccinated in early pregnancy 
(Larson et al. 1971; Ebbin et al. 1972; Vaheri et al. 
1972; Modlin et al. 1976), although the incidence of 
foetal infection appears to be much lower than would be 
expected with wild-type virus. It is not clear whether 
infants infected in utero with the vaccine virus will 
show any post-natal damage. Modlin et al. (1976) found 
no defects in 38 infants born to susceptible mothers 
after vaccination in early pregnancy. Likewise, Preblud 
et al. (19781 found no defects in the offspring of 65 
susceptible women vaccinated during pregnancy, even 
though 2 infants had laboratory evidence of congenital 
infection. It is, however,essential that these infants 
are followed over a number of years in case any more 
subtle problems, such as partial deafness, appear. 
Possibly in the light of these results the Immunization 
Practises Advisory Committee, U.S.A. (1981) suggested 
that rubella vaccination during pregnancy should not 
be a reason to routinely recommend therapeutic abortion. 
1.1.7.2 Therapeutic immuno-therapy 
Where active immunity against infection does 
not exist in, for example, a susceptible pregnant woman 
exposed to rubella, passive immunisation with anti-
rubella immunoglobulin has been attempted. Although 
Peckham (1974) indicated that this may be partially 
effective in protecting the foetus against rubella 
infection, these results are not supported by other 
workers (Butler et al. 1965; Forrest and Menser 1974). 
In fact, there appear to be many problems which mitigate 
against the widespread usage of this treatment: high 
titred serum is not routinely available; the infectious 
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contact may not be apparent if the disease was sub-
clinical; it is extremely important that treatment is 
commenced as soon as possible after contact; the patient 
may not be aware that she 1s pregnant at the time of 
contact. 
CHAPTER l. 2 
REVIEW: THE EFFECT OF PREGNANCY ON THE 
EXPRESSION OF ANTI-VIRAL IMMUNE RESPONSES 
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Pregnancy is the only naturally occurring 
example of successful allografting. The foetus, in an 
outbred mating, expresses paternal Major Histocompat-
ability Complex C~J-IC) antigens but is not rejected by 
the mother. The immunological paradox of pregnancy is 
perhaps best stated by Faulk and McIntyre (1981) who 
noted that, in evolutionary terms, the more primitive 
animals had already developed a complex system of 
c~llular recognition and rejection mechanisms before 
the appearance of eutherians. Thus, if mechanisms for 
the rejection of non-self antigens existed before the 
advent of placentation,how did a system of reproduction 
develop that depended for its survival upon the co-
existence of allogeneic tissues, and the live birth of 
young rather than the laying and hatching of eggs? 
Available evidence suggests that the mother 
does become immunologically primed against foetal MHC 
antigens after 1 or more pregnancies (Kaliss and Dagg 
1964; Hellstrom et al. 1969; Maroni and deSousa 1973; 
Youtananukorn et al.1974; Rocklin et al. l976; Chaouat 
et al. 1979; Bell and Billington 1980; 1981). It has 
also been established th_at immunisation of the mother 
against paternal antigens either before or after 
conception does not affect the course of the pregnancy 
(Medawar and Sparrow 1956; Beer and Billingham 1979). 
It appears, therefore, that the expression of immune 
reactivity against the foetal tissues exposed to the 
mother is either ineffective, suppressed or blocked. 
The mechanisms involved in ensuring that 
allogeneic foetus is not rejected have not yet been 
elucidated although many hypotheses have been put 
forward. The aim of this Chapter is to review some 
these proposals, in particular those which would be 
expected to have a more general influence on the 
maternal immune response against viral infection. 
the 
of 
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1.2.1 Is the gravid uterus an immunologically 
privileged site? 
~ 
It is generally considered that the gravid 
uterus is not endowed with distinctive characteristics 
that make it a favourable site for the implantation of 
allogeneic tissue (Billingham 1964; Beer and Billingham 
1974; Stites et al. 1979). In fact, the occasional 
occurrence of extra-uterine pregnancies suggests that 
the mechanisms involved with the maternal inertia 
against the foetus are probably governed by the foeto-
placental unit (Siiteri and Stites 1982). Nevertheless, 
there is evidence that the decidual tissue situated 
beneath the developing rat zygote may interfere with 
the drainage of embryonic antigen into the maternal 
lymphatics and delay the development of maternal 
reactivity against the foreign antigens (Beer and 
Billingham 1971; Beer et al. 1971). Although this is 
not considered to play a significant role in ensuring 
the survival of the embryo, it may act to delay the 
development of the maternal immune response against 
agents causing intra-uterine infection. 
1.2.2 Trophoblast antigenicity 
In all mammalian species trophoblast is the 
only foetal element in direct and continuous contact 
with maternal tissues in the placenta. In man, other primates 
and rodents, the chorioallantoic placenta is of the 
haemochorial type where the uterine capillaries are 
breached and the trophoblast is bathed in maternal 
blood (Billington 1975). As the placenta is foetal in 
origin, its close juxtaposition to the maternal immune 
response necessitates the existence of mechanisms which 
render the trophoblast insusceptible to rejection. 
These mechanisms may also be relevant in governing the 
expression of anti-viral immunity in the placenta . 
Beer and Billingham (1978) considered that the 
most likely explanation for the non-rejection of all-
ogeneic foetuses by their mothers is that the tropho-
blast is an immunologically privileged tissue. They 
cited 4 reasons for this: 
1). Ectopic pregnancies in various parts of the 
body are usually successful and their demise, 
if it occurs, is not immunologically mediated. 
2) Choriocarcinoma, a trophoblastic neoplasm of 
embryonic origin, is completely refractory 
to transplantation immunity directed against 
paternal antigens. 
3) Trophoblast ttrophectoderm) develops very 
early, before implantation. 
4). Small grafts of trophoblastic tissue obtained 
from ectoplacental cones appear to be 
invulnerable to transplantation rejection. 
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These peculiar properties of trophoblast were 
originally attributed to an electron-dense acidic muco-
protein layer termed fibrinoid which provides a contin-
uous coating of the trophoblast in mice and was thought 
to mask MHC antigens (Kirby et al. 1966). Enzymatic 
treatment of trophoblast to remove this layer was 
shown to restore its immunogenicity (Currie et al. 1968), 
although these results have not been confirmed (Simmons 
et al. 1971; Jenkinson and Billington 1974; Searle et al. 
1975). However, the observation that the fibrinoid 
layer does not occur in all species (Tai and Halasz 
1967; Wynn 1969) suggests that its role in the main-
tenance of pregnancy may be minimal. 
Later evidence indicated that a more cogent 
explanation for the low immunogenicity of trophoblast 
may be that it either lacks or has a low expression of 
MHC antigens at the maternal-foetal interface (Siegler 
and Metzgar 1970; Goodfellow et al. 1976; Faulk and 
Temple 1976; Faulk et al. 1977). Unfortunately, initial 
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investigations into th.is problem were hampered in a 
number of ways. The techniques used to look for MHC 
antigens were often of low sensitivity and specificity. 
Furthermore, instead of looking for antigens on tropho-
blast cells in situ in sections of whole placentas, the 
placental architecture was often disrupted, or else 
placental cells were grown in vitro and then assayed 
(Chatterjee-Hasrouni and Lala 1981; Wegmann 1981). 
Current evidence indicates that, in the mouse, 
paternal H-2K but not Ia antigens are present on tropho-
blast cells at the maternal-foetal interface, although 
the density of these antigens may be low (Wegmann 1981; 
Chatterjee-Hasrouni and Lala 1982). Likewise in the 
human, HLA A, Band C but not DR antigens have been 
detected on some, although not all, trophoblast cells in 
direct contact with maternal tissues (Sunderland et al. 
1981). This labelling is specific rather than via the 
Fe region of the antibody because labelling of mouse 
trophoblast is also observed with F(ab 1 ) 2 fragments 
(Raghupathy et al. 1981}. The finding of paternal MHC 
antigens on trophoblast directly accessible to the 
maternal circulation is perhaps not surprising because 
they have been found on both choriocarcinomas (Shaw 
et al. 1979) and hydatiform moles (considered to be a 
precursor of choriocarcinoma) (Yamashita et al. 1979) 
which are also able to evade the maternal immune response. 
What is the significance of these findings? 
Firstly, the presence of paternal MHC antigens on 
trophoblast renders these cells liable to immunological 
rejection by the mother. Secondly, if maternal MHC 
antigens are also present on trophoblast, according 
to Zinkernagel and Doherty (1979), any infected cells 
displaying viral antigen as well as (in the mouse} 
maternal H-2K or H-2D antigens should be destroyed by 
specific maternal anti-viral cytotoxic T-cells. 
Obviously, the first proposal does not occur and 
there is no evidence for the second. Thirdly, both 
Wegmann (1981) and Chatterjee-Hasrouni and Lala (1982) 
considered that the lack of Ia antigens may weaken or 
eliminate the immune response against trophoblast but 
this concept is not compatible with other evidence. 
For example, Klein (1978} noted that point mutations 
in only the Kor D regions of the mouse H-2 complex 
~ 
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were sufficient to induce allograft rejection. In fact, 
these mutations were actually defined by skin graft 
rejection responses. Furthermore, it is unlikely that 
the lack of Ia antigens on the trophoblast would pre-
clude the induction of an effective maternal immune 
response because the stimulation of a functional trans-
plantation immunity against foetal antigens prior to 
conception does not affect the course of subsequent 
pregnancies (Medawar and Sparrow 1956). 
In summary, if paternal MHC antigens are dis-
played on the surface of trophoblast cells and are 
accessible to the maternal immune response, mechanisms 
must exist which prevent the expression of trans-
plantation immunity against the foeto-placental unit. 
As will be discussed in the next section, some of the 
mechanisms proposed to govern this suppression or 
blocking of maternal immune reactivity in the placenta 
could also have a profound effect on the expression of 
anti-viral immunity. 
1.2.3 Does maternal immuno-suppression explain the 
non-rejection of the allogeneic foetus? 
1.2.3.1 The evidence for a pregnancy-associated 
systemic immuno-suppression. 
A wide range of both specific and non-specific 
immuno-suppressive mechanisms have been observed in 
pregnant subjects. Cells able to suppress various 
immune responses have been detected in pregnancy by 
a number of authors (Hamilton and Hellstrom 1977; Smith 
and Powell 1977; Clark and -McDermott 1978; 1981; 
Chaouat and Voisin 1979; Suzuki and Tomasi 1979), 
and appear to be of at least 3 types: 
a) Thymus-derived lymphocytes which inhibit 
maternal reactivity against cells bearing 
paternal antigens (Smith and Powell 1977; 
Chaouat and Voisin i979). Suppressor 
T-cells have also been shown to non-
specifically decrease antibody responses 
during pregnancy (_Suzuki and Tomasi 19 79) . 
b) A nylon-adherent, non-T-cell present in a 
B-cell enriched, macrophage-depleted fraction 
which also non-specifically decreases 
antibody synthesis (Suzuki and Tomasi 1979). 
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c) A non-T-cell which non-specifically suppresses 
the generation of effector cells of trans-
plantation immunity and develops peak activity 
at the time of implantation (the authors 
consider this to be the time of "grafting") 
(Clark and McDermott 1978; 1981; Clark et al. 
1980). These cells tend to be located in 
the lymph nodes which drain the uterus and 
act selectively against the generation of 
cytotoxic T-cells (Clark et al. 1980). 
They are thought to be hormonally triggered 
and are found in both syngeneic and allogeneic 
pregnancies, as well as mice pseudopregnant to 
sterile males (Clark and McDermott 1981). 
There is a considerable amount of evidence that 
lymphocyte responses may also be depressed by factors 
present in the serum of pregnant subjects. In both 
animals and humans maternal serum has blocked the Mixed 
Lymphocyte Reaction (MLR) (Kasakura 1971; Curzen et al. 
1972; Jenkins and Hancock 1972; Leikin 1972; Revillard 
et al. 1972; Robert et al. 1973; Harrison 1976; Herva 
and Jouppila 1977; Pavia and Stites 1979), decreased 
lymphocyte responses to mitogens (Walker et al. 1972: 
St. Hill et al. 1973; Hsu 1974; Yu et al. 1975), in-
hibited lymphokine production by maternal leukocytes 
in response to paternal antigens (Youtananukorn and 
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Matangkasombut l973; Rocklin et al. 1976), abrogated 
the inhibitory effects of maternal lymphocytes on 
embryonic cell colony formation (Hellstrom et al. 1969), 
and exhibited a strong anfi-inflammatory effect (Stimson 
et al. 1977). These inhibitory factors may include 
hormones (Hagen and Froland 1972), antibodies (Pence 
et al. 1975; Taylor and Hancock 1975; Rocklin et al. 
1976; Stimson et al. 1979); circulating immune complexes 
(Masson et al. 1977) and pregnancy zone protein (Birke-
land et al. 1979). 
Although there is no doubt that the suppression 
of various immune responses by pregnancy serum or 
suppressor cells can be detected by in vitro tests, it 
is not clear whether these phenomena play a similar 
immuno-suppressive role in vivo. This is especially the 
case with the mechanisms which would be expected to 
display a generalised systemic immuno-suppression in 
the mother (e.g., hormones - Hagen and Froland (1972); 
pregnancy zone protein - Birkeland et al. (1979); 
suppressor cells - Clark and McDermott (1981)). 
Although Mims (1976a) considered thut the increase in 
the level of corticosteroid hormone production during 
pregnancy may decrease the pregnant subject's ability 
to control infections, this is not supported by other 
workers who suggest that pregnancy is associated with 
a relatively normal immune reactivity against tumours, 
experimental grafts and infections (Faulk and McIntyre 
1981, Siiteri and Stites 1982). Those examples where 
pregnancy has been associated with an increased sus-
ceptibility or severity of disease (Knox 1950; Weinstein 
et al. 1951; Dalldorf and Gifford 1954: Siegel and 
Greenberg 1955; Campbell 1960; Farber and Glasgow 1968; 
Rao 1972; VanZon and Eling 1980; Khuroo et al. 1981), 
may be explained by the added influence of nutrition, 
environment, genetic make-up, and physical stresses on 
the pregnant subject (Banatvala 1977) . 
Even those mechanisms which are considered to only 
inhibit maternal res ponses against paternal antigens 
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displayed on the trophoblast (_e.g., "blocking" anti-
bodies - Rocklin et al. l976; Stimson et al. l979) have 
to account for 2 characteristics of pregnant hosts noted 
by Beer and Billingham (1979): firstly, the pregnant 
host can act against paternal skin grafts or cells 
without prejudicing foetal survival; secondly, the 
foetus is refractory to adoptive immunisation of the 
host by a specifically immunised syngeneic donor. 
In summary 1 although numerous cell types and 
serum factors from pregnant subjects are able to suppress 
immune responses in vitro, observations of maternal 
immuno-competence during pregnancy suggest that such 
suppressors are not functional in vivo. It is tempting 
to speculate that many of these mechanisms, rather than 
being crucially involved in causing the maternal hypo-
reactivity against the foetus, occur only as a con-
sequence of the pregnant state. This is especially the 
case with phenomena such as the suppressor T-cells 
described by Chaouat and Voisin (1979) which cannot be 
detected in primiparous animals and are only observed 
after several pregnancies. 
1.2.3.2 The evidence for immuno-suppression in the 
micro-environment of the placenta 
Siiteri and Stites (_1982) considered that the 
local release of an immuno-suppressive factor in the 
placenta with non-specific effects on maternal cellular 
immunity could provide an explanation for the lack of 
maternal reactivity against foetal trophoblast. One 
group of candidates for such factors would be the 
hormones produced by the foetus or placenta. In 
humans these can be classified into three groups 
(Biggers 1980): 
a) hormones produced by the placenta independently 
of the embryo and foetus (human chorionic gona-
dotropin, human chorionic somatomammotropin and 
progesterone); 
b} hormones produced solely by the foetus 
(corticosteroids);and 
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c) hormones that are only produced by the joint 
action of the foetus and placenta (oestrogens). 
Siiteri and Stites (1982) suggested that 
progesterone in particular may be important in the 
evasion of the maternal immune response by the foetus 
because it is immuno-suppressive at the high concen-
trations found in the placenta ( 2000 to 5000 ng/g) but 
does not influence lymphocyte function at the lower serum 
concentrations (100 to 150 ng/ml). The demonstrable 
immuno-suppressive effects of progesterone were con-
sidered to include: 
a) anti-inflammatory and graft sparing effects. 
Implants containing progesterone prolonged 
allogeneic or xenogeneic skin grafts, 
although these effects were localised 
around the implant (Siiteri et al. 1977)_; 
b) inhibition of human and murine lymphocyte 
activation and the generation of killer 
T-lymphocytes; 
c)_ inhibition of certain macrophage functions 
and activity; 
d) prevention of immune cell ingress into 
the uterus. 
Siiteri and Stites (1982) noted that, although some of 
these properties are shared with other sex steroids and 
glucocorticoids, it is the selective high concentration 
of progesterone in the placenta which affords immuno-
suppression. If high concentrations of hormones 
produced by the foeto-placental unit do exert a local 
suppressive effect on the maternal immune response 
against foetal antigens, maternal anti-viral immunity 
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may also be compromised in the placenta. This could 
result in the persistence of virus in the placenta 
and may even facilitate foetal infection. This may 
explain the observations of Fox (1977) who noted that 
the placenta is a preferential site for virus local-
isation in many diseases. 
1.2.4 Phagocyte function during pregnancy 
Cells of the macrophage-monocyte lineage are 
important for the clearance of virus during infections 
(McFarland 1974; Doherty and Bennink 1981). During 
pregnancy, although the numbers of circulating mono-
cytes and neutrophils are increased (Plum et al. 1978), 
there is a decrease in the migratory, chemotactic, 
phagocytic and antigen handling capacity of these 
cells (Bjorksten et al. 1978; Nicklin and Billington 
1979; Senelar and Bureau 1979; Bjorksten 1980). These 
impaired functions may result in not only impaired 
inflammatory responses but also increased susceptibility 
to infection (Bjorksten 1980). 
1.2.5 Summation of Chapter 1.2 
Investigations of the reasons why the allogeneic 
foetus is not rejected by its mother are complicated 
because it is difficult to perform experimental man-
ipulations of the pregnancy in vivo. Nevertheless, a 
large amount of in vitro experimentation has provided 
numerous possible explanations for the paradox of 
pregnancy, although it is difficult to assess whether 
these phenomena are functional in vivo or whether they 
have no relevance to foetal survival but occur as a 
consequence of the pregnant state. In a teleological 
sense, any explanation which implicates mechanisms which 
would prejudice the ability of the mother to combat 
infection or neoplastic growth is extremely poor and, 
as Siiteri and Stites (1982) noted, does not fit in 
with the observations of maternal immuno-competence 
during pregnancy. Thus, it seems unlikely that the 
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mechanisms concerned with the maintenance of pregnancy 
will be shown to influence maternal immunity to 
infection, except possibly in the micro-environment 
of the placenta. ~ 
CHAPTER 1.3 
REVIEW: THE PASSIVE TRANSFER OF 
IMMUNITY FROM A MOTHER TO HER PROGENY 
38 
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The passive acquisition of maternal antibodies 
is essential for providing a neonate with protection 
against infection until its own active immune systems 
are developed. Depending on the species, this antibody 
transfer may be either pre-natal, post-natal or both. 
In ungulates, for example, almost all antibody is 
obtained post-natally, after ingestion of colostrum. 
On the other hand, in primates; passively acquired 
antibody is mainly transferred pre-natally, across the 
chorioallantoic placenta. In mice, both pre-natal 
transfer across the yolk sac and post-natal transfer 
occur (Miller 1966), although the colostral and milk 
antibody may provide a more effective protection (Bruce-
Chwatt and Gibson 1956; Brambell 1966; Iida et al. 1973; 
Nejamkis et al. 1975; Breniere and Viens 1980). Porter 
(19761 suggested that this variation between species may 
be due, at least in part, to their different types of 
placentation. Antibody may not transfer to the foetus 
in pigs and ruminants because of their epitheliochorial 
placentation where several epithelial layers are inter-
posed between the maternal and foetal circulations. In 
the haemochorial form of placentation observed in humans 
and mice, there are fewer layers between the circulations 
and this possibly facilitates pre-natal antibody transfer. 
1.3.1 Pre-natal antibody transfer to the foetus 
The maternal antibody class usually transferred 
pre-natally is IgG. The mechanisms involved in its 
transport to the foetus have been studied in a number 
of species. Brambell (1966} initially proposed that the 
transfer of antibody across the rabbit yolk sac to the 
foetus occurred in a number of steps. The yolk sac 
endodermal cells were thought to take up extracellular 
proteins into pinocytic vesicles formed by invaginations 
of the cell membrane. IgG _was thought to be bound to a 
sp~cific receptor on the cell wall which protected it 
against enzymatic degradation. The vesicles then 
transported the IgG to the foetal side of the cell and 
released it into the foetal circulation. This was 
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modified by Wild (1975t who suggested that the IgG 
is attached to receptors on the outside of the yolk 
sac endoderm or, in humans, the syncytiotrophoblast, 
and taken up by micropinocytic "coated" vesicles, so 
called because of characteristic electron dense ridges 
observed on their cytoplasmic surface that involve the 
protein clathrin (Ockleford and Whyte 1977; Huesner 1980). 
These "coated" vesicles have not been observed to fuse 
with lysosomes and therefore provide protection for the 
IgG as it moves across to the foetal side of the cell. 
Although it is generally accepted that receptors for the 
Fe end of IgG do, in fact, occur on human syncytiotroph-
oblast, as yet there is no evidence that the coated 
vesicles reach the abluminal basal plasmalemma and 
discharge their contents (Johnson and Brown 1981). It 
is of interest that IgG molecules from other species 
with significant pre-natal antibody transfer will bind 
to human syncytiotrophoblast receptors, whereas IgG 
obtained from cattle and sheep, with no pre-natal 
transfer, will not (Matre and Haugen 1978; van der 
Meulen et al. 1980). 
1.3.2 Post-natal antibody transfer to the neonate 
A description of the mechanisms involved in 
the post-natal transfer of maternal antibodies to the 
neonate is more complicated because mammalian milks 
differ significantly from each other and appear to be 
tailored for the needs of the individual species. For 
example, in humans, all systemic IgG is gained by the 
foetus before birth, and the role of colostral and milk 
antibodies is mainly to suppress the growth of 
potential pathogens in the neonatal gut, and therefore 
promote a balanced and desirable flora (Reiter 1981). 
IgA predominates in human colostrum, with 5000 mg/day 
being produced in the first week post-partum. The 
concentrations of IgG (50 mg/day) and IgM (70 mg/day) 
are much lower (Ogra et al. 1980). The main function 
of the IgA is probably to neutralise viruses, bind to 
antigens and toxins, and agglutinate bacteria in the 
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intestinal lume n (Carlsson et al. 19801. For this 
reason, the bulk of the IgA is not absorbed and is 
eventually excreted in the faeces (Ogra et al. 1977). 
The lgA present in human colostrum is in the secretory 
llS form (Tomasi et al. 1965), which is especially 
resistant to variations in pH or degradation by enzymes 
(Lindh 1975), and is therefore more suited to the gut 
environment than other antibody classes. It is of 
interest that the antibody activity in human colostrum 
and milk is mainly directed against the commoner 
alimentary pathogens, notably Eschericia coli and the 
enteroviruses (Jelliffe 1976). This may be because 
the specific IgA-producing plasma cells in the breast 
tissue originate from the Peyers patches. Following 
exposure to antigens from the gut, the bulk of these 
cells move into the systemic circulation and selectively 
home to the mammary tissues and other mucosal surfaces 
(Roux et al. 1977; Mellander et al. 1~81). A similar 
mechanism involving the migration of plasma cells from 
the broncho-pulmonary lymphoid tissue has also been 
invoked to explain the presence of antibodies to 
respiratory syncytial virus in human milk (Fishaut et 
al. 1981). 
A contrast to the situation in humans is seen 
in pigs, cattle and horses, where no significant pre-
natal antibody transfer occurs and the major role of 
colostrum is therefore to provide the neonate with high 
serum levels of IgG to enhance its systemic immunity 
(Bullen 19811. Antibody, along with other macromolecules, 
is non-specifically absorbed from the colostrum in the 
intestine but this only occurs in the first 20-24 hours 
after birth (Jeffcott 1974). High concentrations of 
antibody, especially IgG, are present in colostrum 
during this period. For example , in pig colostrum, 
63.6 % of whey protein is immunog lobulin, of whi ch 
79.7 % is IgG, 14.1% is IgA and 6.3 % is IgM. All 3 
classes are absorb e d by th e p igle t so that the post-
colostral serum con c e ntrations of IgG and IgM are 
similar to the adult levels, and the conce ntration of 
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IgA generally exceeds the adult (Porter 1969}. A 
feature of lactation in the pig, however, is the rapidly 
changing antibody profile in colostrum which occurs 24 
hours after birth. The relative antibody concentrations 
then resemble those in human colostrum, with IgA 
replacing IgG as the predominant class. These changes 
are presumably to enhance the intestinal defenses 
against infection (Porter 1976). 
The post-natal transfer of maternal antibody 
to the neonatal mouse and rat is dependent upon 
different mechanisms to those in the pig. In mouse 
colostrum, IgA is present at a concentration of 0.26 
mg/ml, IgM at 0.07 mg/ml, I.gGl at 0.24 mg/ml, IgG2a at 
0.19 mg/ml and IgG2b at 0.03 mg/ml. IgG3 is not 
detectable (Guyer et al. 1976}. Neither IgA nor IgM 
are absorbed by the neonate (Fahey and Barth 1965; 
Guyer et al. 1976}, suggesting that their primary 
protective role is in the intestinal lumen. On the 
other hand, between 30% and 50 % of colostral IgG is 
selectively absorbed lGuyer et al. 1976). The mechanism 
involved in this selective absorption appears to be 
similar to that responsible for the pre-natal transfer 
of IgG to the foetus described earlier in this Chapter. 
Receptors for the Fe end of IgG are present in the mouse 
intestine. The affinities of the different IgG sub-
classes for the receptor are 
lgG2a = IgGl >IgG2b ~rgG3 
(Guyer et al. 1976). In the young rat, these receptors 
are only loc~ted in the proximal region (duodenum and 
jejunum) of the small intestine. Furthermore, they are 
pH-dependent and will only bind IgG at the acid pH 
found in the gut (Wild 1981}. Rodewald (1980) proposed 
that after binding to the receptors, the IgG is trans-
ported from the luminal surface to the abluminal 
surface by "coated" vesicles and is therefore protected 
against intracellular degradation. Exposure of the 
receptors to the serosal plasma which is at a neutral 
pH would probably effect the release of the IgG. 
It is of interest that these receptors cannot be detected 
in the rat intestine after 20 days of life (Wild and 
Richardson 1979), which coincides with the time that 
the neonate loses its ability to absorb IgG from the 
gut (Halliday 1956). 
1.3.3 Other mechanisms involved in the passive 
protection of the neonate by colostrum 
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Passive protection of the neonate by the mother 
is not only mediated by antibody, although this is 
extremely important. In humans, a multifactorial 
defense system against infection is present in colostrum 
and milk and includes lactoferrin, transferrin, lacto-
peroxidase, lysozyme, "bifidus" factor, lipid-associated 
staphylococcal resistance factors, monoglycerides with 
anti-viral activity, components of the complement 
system, interferon, lymphokines, chemotactic factors 
and IgA-stimulating factors (Ogra et al. 1980; Bullen 
1981). There may also be a significant immune cell 
presence. At one day post-partum, human colostrum has 
6 been shown to contain 2.1 x 10 macrophages/ml, 
5.6 x 10 5 neutrophils/ml and 2.4 x 10 5 lymphocytes/ml, 
although these concentrations decrease with time (Ogra 
et al. 19801. The macrophages may be important in the 
defense of both the breast tissue and the neonatal gut 
(Pittard et al. 1977; Pitt 1979; Mellander et al. 1981). 
The lymphocytes, of which 50% are T-lymphocytes (Diaz-
Jouanen and Williams 19741, are responsive to a variety 
of mitogens and microbial antigens in vitro (Ogra and 
Ogra 1978). Although evidence exists that certain 
antigen-specific lymphocyte reactivities may be trans-
ferred from the mother to her neonate by suckling 
(Mohr 1973; Ogra et al. 1977; Schlesinger and Covelli 
1977), it is not clear whether this represents the up-
take of these sensitised cells, or the absorbtion of 
molecular mediators of immunity such as transfer 
factor (Diaz-Jouanen and Williams 1974). 
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CHAPTER 1.4 
INTRODUCTION TO THE THESIS 
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The discovery that viral pathogens can cause 
damage to the foetus in utero was made just over 40 
years ago by Gregg in l94l. Since then, efforts have 
been made to elucidate the various mechanisms utilised 
by viruses in the pathogenesis of foetal infections. 
However, unlike most other host-parasite interactions, 
the pathogenesis of infections during pregnancy is 
complicated because: 
a) two hosts, the mother and the foetus, are 
present, and each has a different genetic make-
up and different level of immune maturation 
and responsiveness; 
bt the placenta, an organ unique to pregnancy, 
is present and may provide another target 
for the pathogen; 
c) the maternal immune response to infection 
may be compromised by the co-existence of 
mechanisms which serve to prevent rejection 
of the allogeneic foetus and its placenta. 
The aim of this thesis was therefore to contribute to 
the understanding of the immunology and pathogenesis 
of in utero virus infections using the laboratory 
mouse as an experimental host. Originally, it was 
intended to use Akabane virus in this study because 
of its importance in causing foetal teratogenesis and 
wastage in farm animals. However, attempts to establish 
foetal infection in the pregnant mouse failed, probably 
because the virus did not produce a viraemia in the 
mother (unpublished results). It was therefore decided 
to use 2 serologically related alphaviruses, Semliki 
Forest virus (SFV) and Ross River virus (RRV) which, 
in preliminary studies, produced highly reproducible 
but different syndromes of foetal infection. There 
have been no reports of the effects of either experi-
mental or natural infections with SFV during pregnancy. 
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On the other hand, RRV has been shown to establish in 
the foetus and placenta followinq the experimental 
infection of pregnant mice (Aaskov et al. 1981a), 
and may occasionally cross the placenta during natural 
disease in humans (Aaskov et al. 1981b). The value 
of using laboratory models to study the pathogenesis 
of in utero infection was emphasized by Fuccillo and 
Sever (1973) who noted,''Further development of animal 
models of congenital viral infections will help 
contribute to our knowledge of the number of variables 
which influence the frequency of congenital infections 
and their pathogenic processes", and Mims (1976b)who, 
in discussing the problems of understanding the patho-
genesis of viral infections of the foetus, noted that 
"As in many aspects of medicine, progress is more rapid 
when a laboratory animal system is available. Naive 
extrapolations to the human situation are rarely 
justified but the animal model at least gives vital 
information about the sort of thing that can happen and, 
compared with clinical research progress can be rapid". 
Thus, although the use of a laboratory model and artif-
icial infection regimens constitutes a rather contrived 
situation, it is hoped that the results obtained from 
such a controlled and reproducible methodology may be 
of value in leading to a greater understanding and 
possibly improved control of natural in utero viral 
infections in both human and veterinary medicine. 
47 
CHAPTER 2 
MATERIALS AND METHODS 
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2.1 Viruses 
The reference strains of alphaviruses used 
in the present study are listed in Table 2.1. Both RRV 
and SFV strain A7 are uniformly lethal for neonatal 
mice but do not cause clinical signs in adult or preg-
nant mice. SFV strain 25639 is lethal for both neonatal 
and adult mice. All stock viruses were prepared as 10% 
(w/v) suckling mouse brain suspensions in normal saline 
and were stored at -65°c. 
2.2 Mice 
All mice were bred by the Animal Breeding 
Establishment in the John Curtin School of Medical 
Research. Outbred mice used for immune ascites fluid 
preparation were multi-coloured Walter and Eliza Hall 
Institute strain mice. The CBA/H inbred strain was used 
for all experiments except where specified in Tables 4.1 
and 5.6. Adults were always between 7 and 10 weeks of 
age. The onset of pregnancy (gestation day 0) was taken 
as the day of observation of a vaginal plug following 
mating. All non-pregnant mice used for comparisons with 
pregnant mice were age-matched CBA/H females. 
Mouse inoculations were performed intraperi-
toneally (i.p.), intravenously (i.v.) and subcutaneously 
(s.c.). 
2.3 Collection and preparation of tissues for 
virus assay 
At harvest, mice were anaesthetised with 
chloroform, then exsanguinated. Tissues were aseptically 
removed, weighed and labelled, and stored at -65°c. 
Subsequently, they were ground in a measured volume of 
gelatine saline using a mortar and pestle with sterile 
sa-nd, spun at 850g for 5 min., and the supernatant was 
removed for virus assay. 
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Table 2.1 Viruses 
Virus Original Source Passage 
strain History 
designation 
Ross River T48 Dr. R. L. Doherty 1 13 smb 2 
Semliki Forest A7 Prof. H. Smith 3 9 smb, 2 4 cec 
Semliki Forest 25639 5 RFVL 6 15 amb, 7 5 smb 
1. Queensland Institute of Medical Research, Brisbane, 
Australia. 
2. smb = suckling mouse brain. 
3. University of Birmingham, England. 
4. cec = chicken embryo cells. 
5. This strain of SFV was only used in Chapter 3, Table 3.5, 
and is termed "virulent" SFV. 
6. RFVL = Rockefeller Foundation Virus Laboratories, New York, 
U.S.A. 
7. amb = adult mouse brain. 
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Serum, collected after centrifugation of the 
clotted blood, was stored at -6s 0 c until use. 
2.4 Cell culture 
Cell line 
Vero cells, originally derived from the kidney 
epithelium of the African Green Monkey (Cercopithecus 
aethiops) were supplied ny the tissue culture laboratory, 
Microbiology department, John Curtin School of Medical 
Research. 
Virus titrations 
Plaque assays were performed on confluent 24 
hour Vero cell monolayers, grown in 60 mm petri dishes 
in Medium 199 (Gibcol with 5% bovine serum, 100 ug/ml 
penicillin, 100 ug/ml streptomycin and 100 ug/ml 
neomycin, and incubated in a humidified atmosphere with 
5% co 2 at 37°c. After draining, replicates of 2 or 3 
monolayers were inoculated with 0.1 ml of the appropriate 
serial virus dilution. Virus was allowed to adsorb to 
the monolayer for 1 hour at 37°c, after which 5 ml of 
an agar overlay was added to each plate. 
The overlay consisted of Earles Salts Solution 
(Gibco) with 0.5% lactalbumin hydrolysate, 0.1% yeast 
extract, 0.1% bovine plasma albumin (fraction V) and 
0.75% Difeo Bacto agar. In addition, all overlays 
contained 100 ug DEAE dextran/ml, 0.05 % sodium bicarbonate, 
2% bovine serum, 0.02M HEPES buffer and antibiotics. 
Plates were incubated at 35°c in a non-gassed, 
non-humidified incubator for 2 days with SFV, or 3 days 
with RRV, when 3 ml of a 0 .01 % neutral red in saline 
solution was added. After re-incubation at 35°c over-
night, plaques were counted. 
Virus titres are expressed as the number of 
plaque forming units per ml (pfu/ml) or per gram 
(pfu/gm) as appropriate. 
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2 . 5 Fractionation of antibodies from serum 
IgG subclasses were fractionated from serum 
by affinity chromatography using a column made from 
.:; 
staphylococcal protein A covalently linked to sepharose 
CL-4B (Pharmacial, according to a modification of the 
methods described by Ey et al . (1978) and Seppala et al. 
(1981). . The IgG binds to the protein A by its Fe end 
whereas all other antibody classes are washed through the 
column. The IgG can then be eluted by lowering the pH 
(Forsgren and Sjoquist 1966; Hjelm et al. 19721. 
Approximately 2 ml of serum was diluted with 
4 ml of 0.14M sodium phosphate buffer pH 8.0, then 
applied to a 5 ml protein A-sepharose column equilibrated 
in the same buffer at 4°c. A linear pH gradient made 
from 150 ml of 0 . 14M sodium phosphate buffer pH 8.0 and 
1 50 ml of O.lM citric acid buffer pH 2.7 was then 
applied . The flow rate was 30-35 ml per hour. Fraction 
s i ze was approximately 2.9 ml . All fractions with a pH 
of less than 5 . 0 were taken into 0.8 ml of lM Tris-HCl 
pH 9 . 0 to neutralise the acidity. After fractionation, 
the column was re-equilibrated to pH 8.0 and used again. 
The protein concentration in each fraction was 
assayed using the micro-method of Rylatt and Parish (1982). 
15 ul of test sample and 85 ul of normal saline were 
added to 100 ul of a O. 06% solution of Coomassie Blue 
(Sigma) in 1.9% perchloric acid in wells of a 96-well 
round bottom plate (Linbro). After 2 min. the optical 
density of the solution was read in a Dynatech ELISA 
spectrophotometer, with test wavelength 630 nm and 
reference wavelength 405 nm . The protein concentration 
of the sample is proportional to the optical density and 
is assessed from the linear section of an optical 
density versus serum albumin standard curve. 
The location of each protein peak eluted from 
the column was then found from a plot of optical density 
versus fraction number. The appropriate fractions were 
pooled, concentrated to approximately 1-2 ml by vacuum 
dialysis, dialysed against normal saline, and stored at 
- 20°c . 
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2.6 Gel diffusion test 
The various immunoglobulins present in the 
protein peaks eluted from the sepharose-protein A 
column were identified by gel-diffusion using rabbit-
anti-mouse antisera (Bionetics) specific for mouse IgA, 
IgM, IgGl, IgG2a, IgG2b (all generously donated by 
Dr. Ian McKenzie, Melbourne University), and IgG3. 
Three ml. of a 1% purified agar (Oxoid) 
solution with 1% NaCl was layered onto a clean glass 
microscope slide. Approximately 10 ul of undiluted 
antisera or the appropriate protein peak was added to 
adjacent, small 2 mm holes punched into the agar layer. 
The slide was incubated overnight in an humidified 
atmosphere at room temperature to allow formation of 
precipitin lines which were only observed when the 
immunoglobulin present in the protein peak was of the 
correct specificity to allow complexing with the 
antiserum. 
2.7 The haemagglutination-inhibition (HI) test 
Anti-viral antibody was assayed in the HI 
test using the Takatsky microtechnique (Sever 1962) 
adapted to the general methods of Clarke and Casals 
(1958). SFV haemagglutinin was prepared by sucrose-
acetone extraction of infected infant mouse brain. 
RRV haemagglutinin was prepared in the same way from 
eviscerated infant mouse carcasses. 
Sera were extracted with acetone and ether to 
remove non-specific lipid inhibitors of haemagglutination. 
Extracted sera were adsorbed with gander erythrocytes 
prior to testing. The test was performed using between 
4 and 8 units of haemagglutinin, and the end-point was 
taken as the reciprocal of -the highest dilution of 
serum which resulted in 50 % haemagglutination. 
2.8 Irnm11nofluorescence (IF) 
An indirect IF method was used for the 
detection and location of viral antigens in frozen 
tissue sections of the foetus and placenta. Eight 
micron sections were cut in a cryostat, mounted on 
gelatin-treated microscope slides, dried at room 
temperature, fixed for 5 min. in acetone at -20°c, 
then stored at -20°c until staining. 
Sections were thawed at room temperature, 
overlaid with an unlabelled mouse anti-virus serum, 
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then incubated at 37°c for 30 min. in a humidified 
chamber. Sections were washed three times in phosphate-
buffered saline, 3 min. per wash , then overlaid with a 
FITC-conjugated rabbit anti-mouse IgG (Miles-Yeda). 
After incubation for a further 30 min. at 37°c in a 
humidified chamber, the sections were washed 3 times 
in phosphate-buffered saline, air dried and mounted 
in 90% glycerol in borate-buffered saline pH 9.0. They 
were examined using a Zeiss fluorescent microscope. 
2.9 Preparation of immune ascites fluid 
Ascites fluid was prepared by the method of 
Tikasingh et al. (1966), using sarcoma 180/TG cells. 
Mice were given 0.2 ml i.p. of a 1:1 mixture of undilute 
virus stock: Freunds complete adjuvant each week for 5 
weeks. Three days before the last injection 0.1 ml of a 
10% sarcoma cell suspension was given i.p. Ascites 
fluid was collected between 10 and 30 days later. 
Normal ascites fluid was prepared from uninfected mice. 
2.10 Preparation of anti - thymocyte serum (ATS) 
ATS was prepared by the method of Levey and 
Medawar (1966). Rabbits were given i.v. injections of 
2 x 10 8 and 10 9 viable CBA/H mouse thymocytes 14 days 
apart, and were exsanguinated 9 days later. Normal 
rabbit serum (NRS) was used as a control for the ATS. 
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Both sera were stored at -20°c. ATS treatment on its 
own did not affect the course or outcome of a normal 
mouse pregnancy. 
2.11 The lymphocyte stimulation test (LST) 
Antigens and mitogen 
Viable virus preparations were used as antigens 
because Griffin and Johnson (1973) showed that they 
induced better proliferation in the LST than inactivated 
virus. Antigens were obtained by infecting confluent 
Vero cell monolayers with RRV or SFV at a multiplicity 
of infection of 1:1. The infected monolayer was grown 
in medium Fl5 (Gibco) with 5% foetal calf serum (fcs) 
(Flow Laboratories) until extensive cytopathic effect 
was observed. The supernatant was then removed, clari-
fied at 850g for 10 min. and stored at -20°c. 
Concanavalin A (Con A), derived from the jack 
bean (Canavalia ensiformis), is a T-cell mitogen 
(Schechter 1980), and was always used as a positive 
control. 
LST methodology 
Variables such as incubation time, cell numbers 
and antigen dosage were initially optimised using spleen 
and para-aortic lymph node cells from infected, pregnant 
mice. The test used in _the present study was as follows: 
Single cell suspensions of spleen or lymph node were 
obtained by pressing the organs through a fine stainless 
steel wire mesh into medium Fl5 with 5% fcs. Lymphocytes 
were isolated from the spleen cell preparation by 
centrifugation in a Ficoll-Isopaque gradient at 20°c for 
20 min. at 2000g, according to the procedures of Davidson 
and Parish (1975). Lymph node cells were used 
unseparated. Th e cell suspensions were washed twice in 
Fl5 and finally resuspended to 2 x 10 6 cells/ml in Fl5 
-4 plus 5% fcs and lO M of 2-mercaptoethanol (Sigma). 
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100 ul of the suspension was dispensed into wells of a 
96-well flat-bottomed tissue culture plate (Linbro) 
along with 50 ul of the appropriate antigen or Con A. 
This corresponded to approximately 6.5 x 10 5 pfu of both 
RRV and SFV. Con A was used at a concentration of 10 ug/ml. 
Between 4 and 8 replicates were used for each assay. 
Plates were incubated at 37°c for 72 hours in a gas 
mixture of 10% co2 , 7% o 2 and 83% N2 . 
The extent of lymphocyte proliferation in 
response to antigen or mitogen was assessed by adding 
0 . 6 uCi of methyl-tritiated thymidine ( 3HTdR) (Amersham) 
in 50 ul of Fl5 with 5% fcs to each well 6 hours before 
the end of incubation. At harvest the cells from each 
well were washed out with distilled water onto Whatman 
GF/A filter paper using a multiple sample harvester 
(Dynatech). Each sample was counted in a Packard model 
3320 scintillation spectrometer. Results were expressed 
either as counts per minute (cpm) or as a stimulation 
index (SI) which was defined as follows: 
SI - cpm with stimulant cpm without stimulant 
Stimulation indices greater than 2.0 were considered to 
indicate a specific response against antigen (Muscoplat 
et al. 1974; Buergelt et al. 1977). 
2 . 12 Measurement of T-cell mediated cytotoxicity 
Target cells for the assay of anti-viral cyto-
toxic lymphocytes were 120-hour thioglycollate-induced 
CBA/H peritoneal macrophages (Mullbacher 1981). 
Approximately 5 x 10 6 macrophages were labelled with 
400 uCi of 51cr (sodium chromate, 200 mCi/mg, CEA 
commissariat A L'energie Atomique) for 1 hour at 37°c 
in a volume of 0.5 ml. They were simultaneously 
infected with 10 to 100 pfu/cell of the appropriate 
virus. After incubation, the cells were washed 3 times 
to remove excess label, and 2 x 10 4 cells were added in 
100 ul of Fl5 with 5% fcs and l0- 4M 2-mercaptoethanol 
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to wells of a 96-well round-bottom tissue culture plate 
(Linbro). 
Single cell suspensions of spleen or lymph 
node effector cells were added in 100 ul amounts to the 
infected target macrophages so that effector:target 
ratios of 30:1, 10:1, 3.3:1 and 1.1:1 were achieved. 
All ratios were performed in triplicate. To enable a 
calculation of the specific anti-viral lysis to be 
performed, effectors were also assayed for their cyto-
cidal activity on target cells that were labelled but 
not infected. Controls were infected and uninfected 
targets with medium only, i.e., no effector cells (medium 
release), and infected and uninfected target cells with 
1% Triton-XlOO (maximal release). After incubation for 
6 hours at 37°c in an atmosphere of 10% co2 , 7% o2 and 
83% N2 , 100 ul of supernatant from each well was assayed 
for the release of 51cr from the target cells in a 
Beckman gamma 9000 spectrometer. 
The% lysis for a particular assay was 
calculated by the formula: 
% lysis test sample release - medium release 
maximal release - medium release x lOO 
Medium release was usually between 10 and 25 %. 
Standard errors of the mean of each triplicate were 
always less than 5%. 
The% specific lysis, attributable to cyto-
toxicity against viral antigens, was calculated by the 
formula: 
% specific lysis 
% lysis on infected targets -
% lysis on uninfected targets. 
2.13 Depletion of T-cells by anti-Thy 1.2 plus 
complement treatment 
T-cells were depleted from a lymphoid cell 
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population to assess their role in the anti-viral 
responses detected in the LST and cytotoxicity assay. 
10 8 spleen or lymph node cells were incubated with 
100 ul of anti-Thy 1.2 serum (OLAC Ltd) for 1 hour at 
4°c. The cells were washed twice and resuspended in 
1 ml of a 1:2 dilution of guinea-pig serum as a source 
of complement for 30 min. at 37°c. The cells were 
washed twice before assay in the LST and cytotoxicity 
test . 
CHAPTER 3 
THE EFFECT OF PREGNANCY ON THE 
STIMULATION AND EXPRESSION OF 
ALPHAVIRUS IMMUNITY IN THE MOUSE 
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INTRODUCTION 
Doherty and Bennink (1981) summarised the 
maJor events involved in the pathogenesis of, and 
recovery from, an acute viral infection. These are 
reproduced in Table 3.1. Whether all these events occur 
in infected pregnant animals is, however, unclear because 
some mechanisms proposed to explain the non-rejection of 
the allogeneic foetus may also compromise the mother's 
anti-viral response (see Chapter 1.2), both in 
allogeneic and syngeneic pregnancies. The experiments 
described in this Chapter were designed to investigate 
this problem. Firstly, the effect of pregnancy on the 
level of in vivo stimulation of T-cell mediated immune 
responses was evaluated in mice following RRV or SFV 
infection using 2 in vitro tests. The first of these, 
the proliferation assay or Lymphocyte Stimulation Test 
(LST), measures the ability of sensitised lymphocytes 
to recognize and undergo clonal expansion in response 
to antigen in vitro, and is considered to be analogous 
to the events that occur in the T-cell populated areas 
of lymphoid tissues during the primary immune response 
in vivo (Mackaness 1978). In the mouse, the prolif-
eration response involves 3 cell populations, of which 
2 are T-cells and l is an antigen-presenting cell (APC). 
One T-cell is antigen-specific and is stimulated to 
proliferate by a H-2I region compatible APC. The other 
T-cell is not sensitised but is recruited into the 
proliferation (Tse et al. 1980). Although this non-
specific component of the response means that measuring 
the level of 3HTdR incorporation may not be as 
accurate a method of assessing the degree of cellular 
sensitisation to antigen as, for example, a 
determination of the actual number of antigen-reactive 
cells (Sohnle and Collins-Lech 1981), the LST has been 
widely used for the detection of immune responses and 
proved easy to perform and quantitate in the present 
study. 
The other test used in the present study 
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Table 3.1 The maJor events involved ,n the pathogenesis of an 
acute viral infectiona 
Day after Major event 
Infection 
1 - 2 Localisation of virus ,n tissues. 
2 - 4 Processing by (or infection of) stimulator cells 1n 
lymphoid tissue is followed by recruitment of 
precursor T-cells and clonal expansion. Similar 
events occur for B-cells, which differentiate into 
antibody-forming plasma cells. 
4 - 5 Secreted antibody neutralises virus 1n blood and 
terminates viraemia. 
5 - 6 Effector T-cells exit from lymphoid tissue and 
enter the blood, either directly (from spleen) 
or via the thoracic duct (from lymph nodes). 
TheseT-cellsthen localise in organs where virus 
7 on 
. . 1 s grow, ng. 
Blood monocytes are recruited into infected tissue 
and differentiate to form activated macrophages. 
Virus is eliminated either as a result of target 
cells being killed directly by T-cells before 
assembly of infectious progeny occurs, or by 
activated macrophages ingesting and killing free 
virus. This is essentially for recovery, but may 
prove fatal if there is a massive synchronous 
destruction of functionally important cells that 
have not previously been physiologically 
compromised by infection with (for instance) a 
nonlytic virus. 
Tissue repair and resolution of the inflammatory 
process. 
a Reproduced from Doherty and Bennink ( 1981). 
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measures the ability of sensitised T-cells to 
specifically recognize and lyse infected target cells. 
These cytotoxic T-cells are considered to be important 
for recovery from viral infections (Zinkernagel and 
Doherty 1979; Doherty and Bennink 1981), and have been 
demonstrated in a number of diseases (Zinkernagel and 
Doherty 1979). Their function in vivo is considered to 
be the lysis of infected cells before infectious progeny 
virus can be produced or released (Zinkernagel and 
Althage 1977). For lysis to occur viral antigen must 
be displayed on the target cell surface and, in the 
mouse, the H-2K and/or D region antigens must be shared 
between the cytotoxic and target cells (Zinkernagel and 
Doherty 1979). 
Experiments were then performed to ascertain 
whether the state of pregnancy affected the in vivo 
expression of this immunity by examining both the 
protective capacity of immune spleen cells from pregnant 
mice compared to non-pregnant mice, and the effect of 
pregnancy on the ability of mice to clear virus from 
their tissues. 
RESULTS 
It was considered that the best way of com-
paring the immune status of pregnant to non-pregnant 
mice following a primary infection was to use multi-
point time-course assays of the different immune 
responses. The responses in 2 lymphoid organs were 
measured: the para-aortic lymph nodes (PALN) which drain 
the uterus (Beer and Billingham 1970), and the spleen. 
The effect of pregnancy on the virus-specific 
lymphocyte proliferative responses. 
Groups of 4 11-day pregnant mice and non-
pregnant controls were harvested at different days 
after i.p. infection with either 2600 pfu of RRV or 
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7000 pfu of SFV. LST responses against specific viral 
antigen were assessed in the spleen and PALN of 
individual mice. With RRV (Figure 3.1), there was little 
evidence of an antigen-induced response in either the 
spleens or PALN of the non-pregnant mice, or in the 
spleens of the pregnant mice. In the pregnant PALN, a 
low degree of reactivity was detected with onset at 
day 6 post infection (p.i.). No reactivity was 
observed at day lO p.i. With SFV (Figure 3.2), the 
responses obtained from the pregnant mice in both 
spleen and PALN were much higher than in the non-
pregnant mice, where little or no reactivity was 
detected. In the pregnant spleen, reactivity to SFV 
antigen was first detected and peaked at day 6 p.i., 
but was not detected at day lO p.i. Responses in the 
pregnant PALN were stronger than the spleen and were 
first detected at day 4 p.i., peaked at day 6 p.i., and 
were still detectable at day 10 p.i. 
In the pregnant PALN and spleen the amount of 
3HTdR label incorporated in the control cultures without 
added SFV antigen showed a small peak at day 6 p.i. 
This was not observed with either oroan in the non-
pregnant controls. 
The antigen-induced proliferation responses of lymph 
nodes other than the PALN from pregnant mice infected 
with SFV. 
An experiment was performed to examine whether 
the proliferation response observed in the PALN following 
infection of pregnant mice with SFV could be detected in 
any other lymph nodes in these animals. 
A group of 4 il-day pregnant mice were infected 
i.p. with 7000 pfu of SFV. At 6 days p.i., the PALN, 
mesenteric and axillary lymph nodes were pooled and their 
responses to SFV antigen were assessed in the LST 
(Table 3. 2) . 
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Figure 3.1 Pro 1 i fer at ion res p()_n~ es _tQ_R_RV _a_llt_i_gen 1 n 
the LST. 
Groups of 4 11-day pregnant mice and non-pregnant 
controls were harvested at different times after 1. p. 
infection with 2600 pfu of RRV. Each point 
+ 
represents the mean - one standard error of the 
individual spleen or PALN LST responses. 
[] = cpm obtained with cells cultured 1n 
medium only 
= cpm obtained with cells cultured with 
RRV antigen 
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Figure 3.2 Proliferation responses to SFV antigen 
in the LST. 
Groups of 4 11-day pregnant mice and non-pregnant 
controls were harvested at different times after 1 .p. 
infection with 7000 pfu of SFV. Each point 
+ 
represents the mean - one standard error of the 
individual spleen or PALN LST responses. 
[] = cpm obtained with cells cultured 1n 
medium only 
~ = cpm obtained with cells cultured with 
SFV antigen . 
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Table 3.2 Antigen-induced proliferation responses of various 
a 
b 
lymph nodes from pregnant animals infected with SFVa 
Lymph node 
para-aortic 
mesenteric 
axi 11 ary 
Amount of label incorporated (cpm) 
Medium only 
2446 ~ 67c 
1204 ~ 73 
+ 952 - 41 
With SFV antigen 
7842 ! 347 
1270 ~ 102 
+ 660 - 102 
Stimulationb 
Index 
3.2 
1. 1 
0.7 
11-day pregnant mice were infected i .p. with 7000 pfu of SFV. 
Various lymph nodes were assayed in the LST 6 days later. 
Stimulation Index= cpm with SFV antigen 
cpm with medium only 
Indices greater than 2.0 are considered to indicate the 
presence of an immune response to antigen. 
c Mean of 6 replicates~ one standard error. 
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A Stimulation Index >2.0 was only observed 
in the PALN suggesting that these nodes were the only 
ones with virus-specific immune reactivity in vivo. 
Identity of the PALN cells which respond to antigen 
in the LST. 
Four 11-day pregnant mice were infected i.p. 
with 7000 pfu of SFV and their PALN were harvested 7 
days later. The PALN cells were pooled and treated with 
either anti-Thy 1.2 antiserum plus complement, or 
complement alone. The results (Table 3.3) indicate that 
most of the resting activity as well as the proliferation 
in response to Concanavalin A and SFV antigen was 
abrogated by the lysis of Thy 1.2-bearing cells, suggest-
ing that T-cells were the major cell type responding to 
antigenic stimulation. 
The effect of pregnancy on the cytotoxic anti-viral 
lymphocyte response following RRV or SFV infection. 
The effect of pregnancy on the time course of 
the primary anti-viral cytotoxic response in spleen and 
PALN was then assessed. Groups of 3 11-day pregnant 
mice and non-pregnant controls were infected i.p. with 
either 2600 pfu of RRV or 7000 pfu of SFV. The cyto-
toxic anti-viral activity in pooled spleens or PALN was 
assessed at various times after infection (Figure 3.3). 
There was little or no cytotoxic activity in either of 
the organs in pregnant or non-pregnant mice following 
infection with RRV. Following SFV infection, a strong 
cytotoxic response was observed in the pregnant spleen, 
rising at day 6 p.i., peaking at day 7 p.i. and still 
detectable at day 10 p.i. Unlike the results obtained 
with the LST, the cytotoxic ·activity in the pregnant 
PALN was weaker than that in the spleen. A low degree 
of anti-SFV cytotoxicity was also obtained from the non-
pregnant spleen. Little or no anti-SFV activity was 
detected in the non-pregnant PALN. 
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Table 3.3 Characterisation of PALN cellsa which respond 1n 
the LST to SFV antigen 
Amount of label incorporated (cpm) 
Treatment 
Medium only Added Added 
Concanavalin A SFV antigen 
Complement only 
Anti-Thy 1.2 serum 
plus complement 
3007 ~ 300b 15822 ~ 355 
2571: 137c 
8734 ~ 436 
1446 ~ 121c 
a 
b 
C 
PALN cells were taken from pregnant mice 7 days after 1 .p. 
infection with 7000 pfu of SFV. 
+ Mean - one standard deviation from 8 replicates. 
Significantly lower than complement only value (Student's 
t test, p <0.01). 
..,,,, 
Figure 3.3 Cytotoxic anti-viral responses in spleen 
and PALN of pregnant and non-pregnant 
mice. 
Groups of 3 11-day pregnant mice and non-pregnant 
controls were harvested at different times after i.p. 
infection with either 2600 pfu of RRV or 7000 pfu of 
SFV. Each point represents the specific lysis obtained 
from pooled organs at an effector:target ratio of 30:1. 
() = specific lysis obtained with pooled PALN 
= specific lysis obtained with pooled 
spleens . 
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Pregnant mice were infected i.p. at gestation 
day ll with 7000 pfu of SFV. At 7 days p.i., the level 
of cytotoxic activity was assessed in untreated, 
complement only treated, and anti-Thy 1.2 serum plus 
complement treated, pooled spleen cells (Table 3.4). 
At all effector:target ratios, treatment with 
anti-Thy 1.2 serum plus complement abrogated the cyto-
toxic response suggesting that the anti-viral cytotoxic-
ity observed was T-cell mediated. The apparent lower 
level of cytotoxicity at effector:target ratios of 30:1 
compared to that of 10:l is probably artifactual and 
due to the re-utilisation of released 51cr label by the 
larger number of effector cells. 
The effect of pregnancy on the ability of SFV-immune 
spleen cells to protect recipient mice against lethal 
SFV challenge. 
Further evidence that the spleen is highly 
stimulated against SFV following infection during 
pregnancy was obtained from an experiment which examined 
the ability of 7 day SFV-immune spleen cells from 
pregnant or non-pregnant mice to protect syngeneic 
recipients against death caused by another, highly 
lethal strain of SFV (virulent SFV). 
Pregnant mice at gestation day 11 and non-
pregnant controls were infected i.p. with 7000 pfu of 
SFV. Seven days later, the spleens in each group were 
pooled and different numbers of spleen cells were given 
i.v. to groups of 5 non-pregnant CBA/H recipients who 
had been infected i.p. with 1000 pfu of virulent SFV 
24 hours earlier. The cytotoxic activity of each spleen 
cell suspension prior to administration to the recipients 
was, for pregnant spleen cells, 50 % specific lysis, and 
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Table 3.4 Characterisation of the spleen cellsa which display 
virus-specific cytotoxic activity following SFV 
infection 
% specific lysis 
Treatment 
30:lb 10: 1 3. 3: 1 1. 1: 1 
Untreated 16.0 30.8 26.0 15.0 
Complement only 26.3 37.9 26.6 20.4 
Anti-Thy 1.2 serum 
plus complement 3.2 -1.4 -1.5 -0.4 
a Spleens were pooled from 2 pregnant mice 7 days after 1 .p. 
infection with 7000 pfu of SFV. 
b Effector:target ratio. 
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for non-pregnant spleen cells, 15% specific lysis, 
both values being obtained at effector:target ratios 
of 20:1. The proportion of recipients protected against 
death with each cell dose is presented in Table 3.5. On 
a cell-to-cell basis, the immune spleen cells from 
pregnant mice afforded much more protection to the 
recipients than those from the non-pregnant mice. 
The effect of pregnancy on the ability of a mouse to 
recover from infection with RRV or SFV. 
Results presented so far in this Chapter 
suggest that following infection with SFV, but not RRV, 
T-cell anti-viral reactivity is markedly enhanced during 
pregnancy. An experiment was therefore performed to 
examine whether this enhanced immunity was actually 
expressed in vivo in the pregnant mouse. This was 
accomplished by assessing the relative abilities of 
pregnant and non-pregnant mice to clear virus from 
their tissues. 
Groups of 3 11-day pregnant mice and non-
pregnant controls were infected i.p. with either 2600 
pfu of RRV or 7000 pfu of SFV. Brain, muscle, spleen, 
liver and serum from each group were pooled at various 
times after infection. All tissues and serum were 
assayed for virus. Serum antibody levels were also 
assessed. 
With both viruses, there was little difference 
between antibody titres in pregnant mice compared to 
non-pregnant mice (Figures 3.4 and 3.5). Furthermore, 
following RRV infection, there was essentially no 
difference between the time course of virus growth in 
spleen, brain, liver and serum in pregnant mice 
compared to non-pregnant mice (Figure 3.4). In muscle, 
RRV titres were higher in pregnant mice early in 
infection and lower in pregnant mice after day 3 p.i. 
Following SFV infection, the virus titres in all 
tissues and in serum from pregnant mice were, 
Table 3.5 
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The effect of pregnancy on the ability of SFV-immune 
spleen cellsa to protect recipient mice against 
lethal SFV infectionb 
Dose of spleen cells Percentage protected C 
per recipient 
spleend Pregnant Non-pregnant spleen 
105 20 0 
106 80 0 
107 100 20 
5 X 107 100 80 
e 
a Donor mice were infected i.p. with 7000 pfu of SFV 7 days prior 
to transfer. 
b Recipient mice were challenged i .p. with 1000 pfu of virulent 
SFV 24 hours prior to i.v. administration of immune cells. 
c 5 mice per group. 
d Spleen cells from pregnant mice had a specific lysis of 
50% at an effector:target ratio of 20:1. 
e Spleen cells from non-pregnant mice had a specific lysis of 
15% at an effector:target ratio of 20:1. 
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Figure 3.5 Growth of SFV in the tissues of pregnant 
compared to non-pregnant mice. 
Groups of 3 11-day pregnant mice and non-pregnant 
controls were infected i .p. with 7000 pfu of SFV. At 
different times after infection various tissues were 
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unexpectedly, always equal to or higher than the 
corresponding titres in the non-pregnant mice (Figure 
3 . 5) . Nevertheless, the actual rate of clearance of 
SFV from the tissues of the pregnant mice appeared to be 
similar to that of the non-pregnants, suggesting that the 
immune mechanisms involved in the clearance of virus were 
operating at the same efficiency in both groups. 
DISCUSSION 
Using in vitro tests to measure the ability 
of sensitised lymphocytes to a) recognize and undergo 
clonal expansion in response to specific antigen, and 
b) specifically lyse infected target cells, the results 
of the present study suggest that the cell-mediated 
immune response to infection with SFV is markedly 
enhanced in pregnant compared to non-pregnant mice. 
The antibody response did not appear to be affected by 
pregnancy. Both cellular responses appeared to be 
mainly T-cell mediated . However, even after anti-Thy 1.2 
plus complement treatment there was still some residual 
proliferation in response to both Con A (a T-cell mitogen 
(Schechter 1980)) and specific antigen (Table 3.3). 
This may be because some T- cells have a low expression 
of Thy 1 determinants and are therefore difficult to 
lyse by the above treatment (Ledbetter et al. 1980). 
Hints as to the reason for the pregnancy-asso-
ciated immuno-stimulation come from the strong prolif-
erative response observed in the PALN, as well as the 
observation that the PALN may be the only nodes with 
this reactivity. Other workers have demonstrated that 
animals immunised with various antigens may display a 
strong immune response in the lymph nodes which drain 
the site of inoculation (Khoury et al. 1981; Snow and 
Hilgard 1981). This is because there is a specific 
seiection of antigen-reactive cells from the 
recirculating lymphocyte pool into antigen-stimulated 
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lymph nodes (Hopkins et al. 1981) resulting in a more 
concentrated population of responsive cells (Griffin 
and Johnson 1973). This enhanced reactivity may also 
be observed in the spleen but only when a high antigen 
load is administered (Nash and Holle 1973). It may 
therefore be hypothesised that in the present study 
following infection with SFV the pregnant animal is 
hyper-immunised by a large antigenic load originating 
in the uterus and passing into the systemic circulation 
through the PALN. This is supported by the results of 
Chapter 4 which show that high concentrations of SFV 
are present in both placental and foetal tissue soon 
after maternal infection. An explanation for the small 
peak in 3HTdR incorporation in control wells (i.e., those 
without added antigen} occurring at 6 days p.i. in the 
PALN of pregnant mice infected with SFV (Figure 3.2) 
may be that a proportion of the antigen draining into 
these nodes is retained by dendritic cells and causes 
the antigen-reactive cells to undergo blastogenesis 
(Nossal et al . 1968) . Thus, their basal rate of label 
uptake would be higher than normal. 
The results of Chapter 4 show that, as well as 
SFV, RRV also grows to high titre in foetal and 
placental tissue following maternal infection. Why then 
do we not see a markedly enhanced stimulation of the 
anti-RRV T-cell mediated immune responses in these 
mothers? One possible explanation is that the intra-
uterine viral antigen is, under normal circumstances, 
relatively inaccessible to the mother's lymphatic system, 
and thus her immune response, but is made more available 
to the mother after the abortion always observed 
following infection with SFV at gestation days 10 or 11 
but never with RRV (see Chapter 4). This hypothesis is 
based upon a number of experimental observations. It 
has been established by Barker and Billingham (1968) 
that intact lymphatic drai~age from the site of 
allografting is an essential prerequisite for the 
sensitisation of the host to antigen but not the 
expression of the response against the antigen. In 
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the pregnant uterus, however, the decidual tissue which 
develops beneath the placenta and experimental homografts 
may interfere with maternal sensitisation against foreign 
intra-uterine antigens, although it does not affect the 
expression of transplantation immunity (Beer and 
Billingham 1971; Beer et al. 1971). This indicates that 
the decidual tissue blocks the entry of these antigens 
into the maternal lymphatic system. While this is not 
considered to play a major role in ensuring the success 
of the foetal allograft (Beer and Billingham 1971), it 
may delay or diminish the stimulation of immunity against 
virus within the pregnant uterus. The tissue disruption 
associated with SFV-induced abortion may bypass this 
apparent "lymphatic blockade" by the decidual tissue 
making viral antigen from the foeto-placental unit more 
available to the maternal immune system, perhaps by 
mechanisms analogous to those involved in maternal 
sensitisation against human foetal Rh antigens following 
a placental bleed at birth (Raitt 1974). The occurrence 
of abortion at 3~ to 5 days p.i. (Eigure 4.6) would 
probably be in time to induce the immuno-stimulation 
which peaked at days 6 to 7 p.i. (Figures 3.2 and 3.3). 
Using a similar hypothesis it could be argued 
that the availability of RRV antigen in infected foetal 
and placental tissue to the mother's lymphatic system 
may also have been increased following parturition, at 
days 8 to 9 p.i. (~.e., gestation days 19 to 20). 
However, this would have been too late to influence 
the initial stimulation of the immune response which was 
first detected in the PALN at day 6 p.i. (Figure 3.1) ~ 
Although the proliferative response to SFV 
antigen was higher in the pregnant PALN than in the 
spleen, the reverse was true with the cytotoxic response. 
The reason for this may be dependent on the observation 
that different T-cell subsets are involved in the 2 
responses. Cantor and Boyse (1975) noted that peripheral 
mouse T-cells could be divided into 3 distinct sub-
classes on the basis of their differential expression 
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of Ly-1, Ly-2 and Ly-3 surface antigens. Cells 
+ displaying Ly-2 and Ly-3 antigens (i.e., Ly-23) 
appeared to be cytotoxic whereas Ly-1+ cells were 
helper cells for antibody production and had little 
cytotoxic activity. All cell groups proliferated in 
response to antigen. Thus, a different distribution 
of these T-cell subsets between the spleen and PALN in 
the present study would explain this phenomenon. An 
alternative explanation may be that the PALN in pregnant 
animals contains suppressor cells which non-specifically 
inhibit the generation of cytotoxic T-cells (Clark et al. 
1980; Clark and McDermott 1981) but do not appear to greatly 
affect the proliferative responses to antigens or 
mitogens (Anderson 1978; Suzuki and Tomasi 1979). 
Although the T-cell mediated immune response, 
as detected in vitro, was enhanced following SFV 
infection during pregnancy, virus titres in all organs 
examined tended to be higher in pregnant mice compared 
to non-pregnant mice (Figure 3.5). This appears 
paradoxical in the light of clinical and experimental 
observations which indicate that the generation of 
specific effector T-lymphocytes plays a critical role in 
recovery from primary virus infections (Woodruff and 
Woodruff 1975; Zinkernagel and Doherty 1979; Doherty and 
Bennink 1981). On their own, these results could be 
taken to indicate that the expression of anti-viral 
immunity is compromised during pregnancy. However, this 
would not be in accordance with the observations of 
Faulk and McIntyre (1981) and Siiteri and Stites (1982) 
who noted that pregnancy is associated with a relatively 
normal immune reactivity against tumours, skin grafts 
and infections. It would also be at variance with a 
number of other results from the present study. For 
instance, although Figure 3.5 indicates that titres of 
SFV are higher in the pregnant group, both the time of 
onset of the viral clearance mechanisms and the rate of 
viral clearance is similar in all tissues of the 2 groups. 
Furthermore, on a cell-to-cell basis, immune spleen cells 
from pregnant animals provide much greater protection 
against lethal infection with SFV than the same cells 
from non-pregnant animals (Table 3.5). This is 
associated with enhanced cytotoxic activity and is 
probably not due to increased production of antibody 
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by the pregnant spleen because the serum antibody titres 
appear to be unaffected by pregnancy (Figure 3.5). 
Finally, the differential between organ titres in 
pregnant animals compared to non-pregnant animals is 
not observed with RRV infection (Figure 3.4), suggesting 
that it is peculiar to the pathogenesis of SFV infection. 
It is tempting to speculate that the reason for these 
results, at least after the time of abortion, may again 
be linked to the previously proposed large stimulus of 
SFV antigen passing from the uterus to the mother's 
lymphatic system. In effect, this might mean that the 
pregnant animals were receiving a much higher and 
possibly more prolonged dose of infectious virus. 
Therefore, the SFV growth curves obtained in the 2 groups 
in Figure 3.5 may not be strictly comparable. Possibly 
a better measure of the relative extent of expression of 
anti-viral immunity in pregnant animals is obtained from 
Table 3.5 where the in vivo protective capacity of immune 
spleens from both groups of mice was assayed in 
recipients challenged with the same dose of virus. 
In conclusion, this study has produced no 
evidence that the state of pregnancy per se is associated 
with a systemic depression of either the stimulation or 
expression of anti-viral immunity in the mother. On the 
contrary, when foetal or placental infection occurs, the 
intra-uterine viral antigen may even cause an enhancement 
of the mother's T-cell anti-viral responses. These 
results would not be predicted from those of other 
workers who detected numerous non-specific cellular and/ 
or humoral immuno-suppressive mechanisms in pregnant 
subjects (Reviewed in Chapter 1.2). These phenomena 
were considered to be important for the continuation of 
an outbred pregnancy by suppressing the immunological 
rejection of the allogeneic foetus by the mother. As was 
noted in section 1.2.5, however, in a teleological sense, 
any explanation for the immunological "paradox" of 
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pregnancy which implicates mechanisms which would 
prejudice the ability of the mother to combat infection 
or neoplastic growth is extremely poor, and does not fit 
in with the observations of maternal irnrnuno-competence 
during gestation. Nevertheless, the results of this 
Chapter do not rule out the possibility that irnrnuno-
suppressive mechanisms may operate in the micro-
environment of the placenta to prevent maternal reactivity 
against trophoblast. If this is the case, immune responses 
against virus-infected trophoblast may also be compromised. 
CHAPTER 4 
THE EFFECT ON THE PREGNANCY OF MATERNAL 
INFECTION WITH ROSS RIVER VIRUS 
OR SEMLIKI FOREST VIRUS 
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INTRODUCTION 
In Chapter 3 it was established that both RRV 
and SFV replicate in the maternal tissues of the 
pregnant mouse without causing any apparent ill-effects 
in the mother . Furthermore, these infections were 
limited, in both cases recovery being associated with 
the formation of cell-mediated and humoral immune 
responses. It was suggested that the strong anti-viral 
activity detected in the PALN following SFV infection and, 
to a lesser extent, RRV infection, resulted from a large 
viral antigen stimulus originating in the uterus and 
moving into the mother via her lymphatic system. This 
Chapter therefore concentrates on the foeto-placental 
unit and how it is affected by maternal infection with 
these viruses. 
As was noted in Chapter 1, the majority of 
maternal infections during pregnancy are inconsequential 
for the foetus. Nevertheless, some viruses are able to 
adversely affect foetal development because of changes 
in the health and continued well-being of the mother or 
placenta, or by direct infection of the foetus itself. 
The factors which determine whether or not a foetus will 
be infected following maternal virus disease are diverse 
and include virus virulence and tropisms, previous 
maternal exposure to virus or vaccine, immuno-competence 
of the foetus, stage of gestation and, possibly, host 
genotype. The placenta may also play a role as a 
"barrier" against trans-placental passage of the virus. 
The experiments described in this Chapter 
examine the time-course of events in the placenta and 
foetus following maternal infection with RRV or SFV. 
It was hoped that this would provide an understanding 
of aspects of the pathogenes_is of the resulting foetal 
diseases, with particular reference to the mechanisms 
of virus entry and growth in placental and foetal 
tissue; the consequences of foetal infection; the 
effect of the onset of the maternal immune response 
on the course of the pregnancy; and the role, if any, 
of the placenta as a barrier to infection. 
RESULTS 
Time course of events following maternal infection 
with RRV. 
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Groups of 4 or 5 ll-day pregnant mice were 
infected i.p. with 2600 pfu of RRV, and killed at 
various times after, up to day 7 p.i. Serum, placentas 
and foetuses were taken for virus assay. Viraemia was 
detected in most mice at day 1 p.i., all mice at day 
1.5 p.i. and peaked at day 2 p.i. (Figure 4.1). Virus 
was not detected at day 3 p.i. The rise in serum 
antibody titre inversely reflected the decline in the 
viraemia (Figure 4.1). 
Time course of growth of RRV in placental tissue 
The time of appearance and concentration of 
RRV was assayed in the individual placentas from these 
mothers (Figure 4.2). Virus was first detected in a 
proportion of theplacentas harvested 1 day after 
maternal infection, corresponding to the time of onset 
of the maternal viraemia (Figure 4.1). Placental 
titres rose rapidly until days 2 to 3 p.i., and were 
still high at the end of the experiment at day 7 p.i. 
After day 1 p.i., all placentas contained virus, and by 
day 2 p.i., the level of virus in most placentas 
exceeded that in blood. There was no difference 
between the placental virus titres from dead foetuses 
compared to living foetuses. Abortion was not observed. 
Time course of growth of RRV in foetal tissue 
The foetuses from these mothers were 
individually assayed for virus (Figure 4.3). RRV was 
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first detected at high titre in some foetuses from the 
mothers harvested at 3 days p.i. This was 2 days after 
the initial detection of virus in the placenta. Low titres 
of RRV were detected in 2 foetuses harvested earlier than 
day 3 p.i., but these may have resulted from post-mortem 
contamination by virus from placental lesions. Live but 
infected foetuses were obtained at days 3, 4, 5 and 6, 
but not day 7 p.i. Apparently uninfected, living foetuses 
were obtained at all times following maternal infection, 
although their numbers decreased with time. All mothers 
had at least one uninfected foetus. 
As indicated in Figure 4.2, one dead foetus was 
observed on each of days 3 and 4 p.i., and large numbers 
were seen on days 5, 6 and 7 p.i. The time interval between 
the onset of foetal infection and that of foetal death 
suggested that death occurred approximately 2 days after 
in utero infection. All dead foetuses contained virus, 
usually at high concentrations. Until approximately 6 
days p.i., dead foetuses were usually small and pale, often 
with extensive peripheral and trunk haemorrhages. Those 
seen after this time were often darker in colour and 
mummified. No gross anatomical abnormalities were seen. 
There was no significant difference between the weight of 
live foetuses from infected mothers at gestation day 18 
+ + (mean - S.D. = l.01 - 0.10 g; n = 23) to those from 
uninfected mothers at the same stage of gestation (mean 
± S.D. = 1.01 ± 0.09 g; n = 66). A typical pregnancy 
6 days after maternal infectionwithRRV is presented in 
Figure 4.4. 
Time course of events following maternal infection 
with SFV 
A similar time course experiment was performed 
with SFV. Groups of 11-day pregnant mice were infected 
i.p. with 7000 pfu of SFV and harvested at different 
times after inoculation. Individual sera from 4 mice 
at each harvest time were assayed for virus and HI 
antibodies (Figure 4.5). Viraemia was first detected 
at 1 to 1~ days p.i., peaked at 3 days p.l., and was 
Figure 4.4 A typical pregnancy 6 days after 
1.p. infection of an 11-day pregnant mouse 
with 2600 pfu of RRV. The uterine wall is 
opened exposing the foetuses within their 
membranes. Two dead foetuses (arrowed) 
and 4 living foetuses are present. Note 
the dead foetus on the right has a distal 
tail haemorrhage. 
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undetectable in all animals at 5 days p.i. The 
ris_e in serum antibody inversely reflected the decline 
in viraemia. 
Time course of growth of SFV in placental tissue 
Because infection with SFV caused abortion in 
some animals, both the individual placental virus titres 
and the proportion of infected mice that aborted at each 
assay time are presented CFigure 4.6). Aborted tissues 
were not available for virus assay because the mother 
usually cannibalized dead and moribund foetuses and 
their placentas immediately after birth. 
Abortion was first observed in some mice at 
3.5 days p.i., and all mice had aborted in the groups 
harvested at day 5 and day 6 p.i. Virus was first 
detected in placental tissue at 2 days p.i., just after 
the onset of the maternal viraemia (Figure 4.5}. After 
this time, the level of virus in most placentas exceeded 
that in blood. 
Time course of growth of SFV in foetal tissue 
The amount of virus in individual foetuses was 
determined (Figure 4.7). Because of abortion, few dead 
foetuses were observed following SFV infection of pregnant 
mice, although all had high virus titres. Dead foetuses 
were usually pale, with extensive peripheral and trunk 
haemorrhages. No anatomical abnormalities were observed. 
Foetal infection was first observed in a group of 
mothers harvested at 3 days p.i. This was 1 day after 
the initial detection of virus in placental tissue, 
although the time of onset of foetal infection did not 
appear to be uniform because both mothers harvested at 
4 days p . i. had uninfe cted foetuses. Where foetal 
infection occurred, it tended to be detected in all 
foetuses within a particular pregnancy, i.e., an "all 
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or nothing" situation. This contrasts with the 
situation observed with RRV. Although it could not 
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be proved that foetal infection preceded abortion, one 
mother that had commenced abortion at the time of 
harvest (3.5 days p.i.) had one expelled, infected, 
dead foetus with no visible placenta and three live 
foetuses with virus titres >10 8 pfu/g in utero. 
(These results are included in Figures 4.6 and 4.7.) 
The effect of infection with RRV on pregnant mice at 
different stages of gestation 
The experiments described so far in this 
Chapter have all involved infection of the mother at 
gestation day 11. An experiment was therefore 
performed to determine the effect of maternal infection 
at other stages of pregnancy. 
Groups of 4 or 5 pregnant mice were infected 
i.p. with 2600 pfu of RRV at day 5, 7, 10, 13 or l6 of 
pregnancy. All mothers were harvested at gestation 
day 18 and individual foetuses and placentas were 
assayed for their virus content. Abortion was not 
observed at any time. Virus was detected in all but 
15 placentas obtained from mothers infected at either 
gestation day 5 or day 7 (Figure 4.8). An extremely 
wide variation in placental virus titres was observed 
in the mothers infected at gestation day 5. 
Uninfected, living foetuses were observed in 
all groups (Figure 4.91. With only one exception (a 
mother infected at gestation day 10)., all mothers had 
at least one living, uninfected foetus. Infected, 
living foetuses were mainly observed in the group 
infected at gestation day 13, suggesting that this was 
the predominant group where active foetal infection 
was occurring at the time of harvest. It is presumed 
that there was insufficient time for foetal infection 
to occur in the group infected at gestation day 16. 
10 l 
D 
9- • 
8 
7 
(1) 
::::> 
<.n 
<.n 
- 6 
0 
-C 
(1) 
u 
0 5 
Cl. 
~ 4 ::::> ~ 
Cl. 
0 
,--
0) 
0 3 
2 
1 
0 
0 
D 
= placenta from live foetus D 
placenta from dead foetus 8 = i rn D 
-
rn 
' 
D 
• 
-D 
D D 
8 
D £ -D 
~ OJ D 
[I] D 
D 
D 
rra 
• 
D 
D § 
~ [I] 
5 7 10 13 
gestation day of inoculation 
Figure 4.8 Effect of infection of mice with 
RRV at different stages of 
gestation: Placental virus titres. 
Groups of 4 or 5 mice were infected i.p. with 
2600 pfu of RRV at day 5, 7, 10, 13 or 16 of 
gestation. All groups were harvested at 
gestation day 18. Virus titres in individual 
placentas are plotted against day of 
inoculation. 
8 
D 
D 
65 
' EHE ~ D 
D 
16 
10 
D = 
9 • = 
8 
7 
Q) 
::> 
Vl 
Vl 
-
6 
0 
-Q) 
0 
...... 5 CJ) 
';---
...... 
Cl. 
0 4 
.--
CJ) 
0 
3 
2 
1 
0 
0 
living foetus 
dead foetus • • 
-
-
-
• 
-• 
• 
• 
• 
D 
D 
o:::rn 
ITO 
o:::rn [I] D IT] DD 
' 
D 
' 
~ 
' 
5 7 
Figure 4 . 9 
10 13 
gestation day of inoculation 
Effect of infection of mice with 
RRV at different stages of 
gestation: Foetal virus titres. 
Groups of 4 or 5 mice were infected i.p. with 
2600 pfu of RRV at day 5, 7, 10 , 13 or 16 of 
gestation. All groups were harvested at 
gestation day 18. Virus titres in individual 
foetuses are plotted against day of 
inoculation. 
16 
82 
Low titres of virus were detected in a few foetuses 
in the groups infected at gestation day lQ or 16, but 
this may have been due to low--level contamination from 
the placenta. Foetal death was observed in all groups 
except those infected at day l6. All dead foetuses had 
high titres of virus except those from the group 
infected at day 5. Infection at gestation day 10, with 
a foetal loss of 40%,proved to be the most detrimental 
to the pregnancy, although it would be expected that a 
considerable number of those foetuses in the group 
infected at gestation day 13 would also have eventually 
died. 
The effect of infection with SFV on pregnant mice 
at different stages of gestation 
Groups of 4 or 5 mice were infected i.p. with 
7000 pfu of SFV at gestation day 5, 7, 10, 13 or 16. 
All groups were harvested at gestation day 18. 
Abortion was not observed in groups infected 
at gestation day 5 or 16, but was observed in some 
animals infected at gestation day 7 or 13 1 and in 
all mice infected at gestation day 10 (Figure 4.10). 
There may have been insufficient time for abortion to 
occur in the one mouse remaining in the day 13 group, 
and in all the mice infected at gestation day 16. Of 
the mice that did not abort, the only placentas without 
virus were 9 from mice infected at gestation day 5. 
Some foetal death and resorption was observed in the 
mice infected at gestation day · 5 or 7, although not 
all dead foetuses contained virus (Figure 4.11). Dead 
foetuses were not observed in the mice that had not 
aborted after infection at gestation day 13 or 16. 
All mothers that had not aborted at the time of harvest 
had at least one apparently uninfected foetus. 
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The detection of viral antigen within infected 
placental tissue 
83 
Frozen sections of infected placental tissue 
were examined for the presence of viral antigen by an 
immunofluorescence technique . 
With both viruses, 5 days after maternal 
infection multiple, small foci of between 1 and 20 cells 
containing viral antigen were detected in the spongio-
trophoblast layer (Figures 4.12, 4 . 13 and 4.14). With 
RRV , staining was limited to the spongiotrophoblast, 
but with SFV extensive fluorescence was often observed 
in lines of contiguous cells in the labrynthine layer 
(Figure 4 . 1 3 }. 
The effect of maternal infection with RRV or SFV 
in different mouse strains 
An experiment was designed to examine whether 
the occurrence of in utero infection with RRV or SFV 
was linked to the presence of the CBA/H strain 
genotype or, alternatively, whether placental and 
foetal infection could be expected to occur in all 
mouse strains irrespective of their genetic make-up. 
Groups of 4 pregnant mice from each of 5 
commonly used mouse strains were infected i.p. with 
either 2600 pfu of RRV or 7000 pfu of SFV at gestation 
day 10 . Foetuses and placentas were removed at 4 days 
p.i . and pooled for virus titrations. The results are 
summarised in Table 4.1. 
Virus was detected at similar levels to that 
described previously in all placental pools in each 
strain for each infection. Virus was also detected 
in most foetal pools . In the 4 days between infection 
and harvest, abortion was not observed following RRV 
infection, but was seen in 3 of the 5 strains infected 
Figure 4.12 Immunofluorescence: foci of viral 
antigen in spongiotrophoblast 5 days after 
maternal i.p. infection with 2600 pfu of RRV 
(x 132). 

Figure 4.13 Immunofluorescence: foci of viral 
antigen in spongiotrophoblast 5 days after 
maternal i.p. infection with 2600 pfu of RRV 
(Top), and in the labrynthine layer after 
maternal i.p. infection with 7000 pfu of SFV 
(Bottom). (Both x 33) 
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Figure 4.14 Immunofluorescence: foci of viral 
antigen in spongiotrophoblast 5 days after 
maternal i.p. infection with 7000 pfu of SFV. 
(x 132) 
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1 Table 4.1 The effect of infectiona with RRV or SFV 'during pregnancy in different mouse strains 
RRV SFV 
Strain haplotype 
Abortion Foetal Placental Abortion Foetal Placental 
Infection Infection Infection Infection 
CBA/H k b +c + + + + -
Balb/c d - + + - + + 
A/J a - + + + + + 
.. 
DBA/1 q - + + - + + 
NZB d - + + + + + 
a Groups of 4 pregnant mice were infected i.p. with either 2600 pfu of RRV or 7000 pfu of SFV 
at gestation day 10. 
b - signifies not observed to occur. 
c - signifies observed. 
with SFV. If th.e time between infection and harvest 
had been extended beyond 4 days it is possible that 
SFV may have induced abortion in all of the infected 
strains. 
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These results suggest that, following infection 
of pregnant mice with either RRV or SFV, placental and 
foetal infection occurs irrespective of the maternal 
genetic make-up. 
The role of the maternal immune response in the 
outcome of in utero infection with SFV 
The role of the maternal anti-viral immune 
response in the pathogenesis of in utero infection with 
SFV was examined. Initial investigation concentrated 
on the coincidence between the onset of detectable 
T-cell anti-viral activity in the PALN and the 
occurrence of abortion. Both events are first detected 
at 3.5 to 4 days p.i. (Figures 3.2 and 4.6). Thus, the 
possibility that the abortion caused by SFV may have 
been triggered by a T-cell mediated immuno-pathological 
process was investigated by observing the effect of an 
ATS-induced T-cell depletion on the course of the 
infection. 
Groups of pregnant mice were given O.l ml s.c. 
of either ATS or NRS at gestation days 9, 10, 11, 12, 13, 
14 and 15, and were infected i.p. with 7000 pfu of SFV at 
gestation day 11. The days that abortion occurred and 
the antibody titres of the pooled maternal sera are 
presented in Table 4.2. The proliferative responses _to 
Concanavalin A and SFV antigen in individual PALN and 
spleens from both groups were assessed in the LST at 
day 7 p.i. (Table 4.3). Other pregnant mice were treated 
with ATS or NRS and infected in the same way but were 
killed 3 days afte r infe ction to examine the effect of 
T-cell depletion on the titres of virus in the foetus, 
placenta and maternal serum (Table 4.4). 
Table 4.2 The effect of anti-thymocyte seruma on the time of 
abortion and on maternal serum antibody titre 
following infectionb with SFV 
Group Time of abortion Maternal serum 
86 
(Days after infection) HI antibody titre 
ATSc 4· 
' 
4; 4; 4; 5 1: 80 
NRSd 3; 4; 4; 4 1: 80 
a 0 .1 ml of ATS or NRS was given s.c. on each of days 
9, 10, 11, 12, 13, 14 and 15 of gestation. 
b Both groups were infected with 7000 pfu of SFV at 
gestation day 11. 
C The ATS group had 5 mice. 
d The NRS group had 4 mice. 
87 
Table 4.3 The effect of anti-thymocyte seruma on cells in 
Group 
ATS 
ATS 
NRS 
NRS 
the spleen and para-aortic lymph nodes of SFV-
infectedb pregnant mice~ as measured by proliferative 
responses to antigen and mitogen in the lymphocyte 
stimulation test 
Organ Proliferative response (cpm) 
medium only Concanavalin A SFV antigen 
spleen 368 ~ 203cd + 1255 - 728d + 207 - lOle 
PALN 248 ~ 82 d + 842 - 525d + 240 - 96d 
spleen + 1829 - 271 + 43739 - 6140 + 2068 - 820 
PALN + 1627 - 363 + 57829 - 1637 + 11845 - 2137 
a 0.1 ml of ATS or NRS was given s.c. on each of days 9, 10, 11. 
12, 13 14 and 15 of gestation. 
b Both groups of mice were given 7000 pfu of SFV i .p. at 
gestation day 11 and killed 7 days later. 
c Mean~ S.E. of responses of individual organs from 5 mice 
in ATS group and 4 mice in the NRS group. 
d The difference between the ATS value and the NRS value 1s 
significant, p < 0.01 (Student's t test). 
e The difference between the ATS value and the NRS value 1s 
not significant. 
Table 4.4 
Treatment 
ATS 
NRS 
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a The effect of anti-thymocyte serum on virus titres 
in the foetus, placenta and maternal serum following 
infectionb witn SFV during pregnancy 
Mouse Virus titrec 
Living Dead Placenta Maternal 
foetus foetus . serum 
1 9.0(6)d -(0) 6.5 4.3 
2 9.0(5) 9.7(1) 6.4 5.2 
3 6. 8()} -(0) 5.9 7.0 
4 9.6(_3)_ 9.5(4) 7.7 6.8 
1 < 2. 0 (_6) -co) 4.3 6.2 
2 < 2.0(6} -( 0). 5.0 6.2 
3 2.6(_5) -(0) 5.9 4.2 
4 < 2.0(7) -(0) 5.0 6.5 
a 0.1 ml of ATS or NRS was given s.c. on each of days 9, 10, 
11, 12 and 13 of gestation. 
b Both groups of mice were infected with 7000 pfu of SFV at 
gestation day 11 and killed 3 days later. 
c Expressed in log10 pfu/g or log10 pfu/ml. 
d The numbers in brackets are the number of foetuses present. 
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These results indicate that ATS treatment 
has a strong in vivo influence on T-cell mediated immune 
responses. Proliferation responses against mitogen and 
antigen in the LST were significantly reduced by ATS 
(Table 4.3), although there was no effect on the serum 
antibody titre (Table 4.2). Even so, this depression of 
T-cell immunity did not appear to influence the outcome 
of the infection because abortion occurred at a similar 
time to the control group (Figure 4.21. Thus, there was 
no evidence that the abortion which may be observed 
following maternal infection with SFV was caused by 
T-cell mediated immuno-pathological processes. 
It was of interest that the titres of SFV in 
the foetal and placental tissues at 3 days p.i. (Table 
4.4) indicate that intra-uterine infection may have 
been more advanced following ATS treatment, although 
this was not reflected in a noticeably earlier time of 
abortion. 
DISCUSSION 
Close similarities exist between the patho-
genesis of in utero infections with SFV and RRV despite 
their differing clinical syndromes. With both viruses, 
the placenta probably became infected following a 
haematogenous virus spread from the site of inoculation 
in the mother. Foetal infection, however, occurred at 
least 1-2 days after the initial detection of virus in 
the placenta, at a time when the maternal viraemia was 
declining. Foetal infection was therefore less likely 
to have occurred from a direct seeding of virus from 
the maternal circulation and was probably dependent 
upon viral replication in the placenta. Foetal death 
appeared to be a direct consequence of viral replication 
in foetal tissue. 
With both RRV and SFV, the placenta appeared 
to play a critical role in the pathogenesis of the in 
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utero infections. Foetal infection was probably aided 
by the apparent predilection of both viruses for 
placental tissue, and their subsequent growth to high 
-'< 
titre in that organ. Furthermore, both viruses were 
able to persist at high titre within the placental 
tissue even though the moth~rs were able to mount 
humoral and cell-mediated anti-viral immune responses 
which were able to clear virus from their own tissues 
(see Chapter 31. This may be because placental virus 
is not accessible to an effective maternal immune 
response. For example, 1t1aternal IgM, produced in the 
initial phase of infection does not cross into the 
foetal circulation (_Fahey and Barth 1965}. Maternal 
IgG does cross the mouse placenta (Fahey and Barth 1965; 
Grey et al. l971) but, at least in the first week after 
infection, does not appear to be present in sufficient 
amounts to clear virus from foetal tissue. The low or 
undetectable virus titres in some placentas and dead 
foetuses from mothers infected at gestation day 5 and 
harvested at gestation day 18 (Figures 4,8, 4.9 1 4rl0 
and 4.11). suggest that a minimum of 13 days may be re-
quired after infection before any anti-viral effect of 
maternal IgG is expressed in foetal tissue. 
It is also possible that virus infecting 
trophoblast tissue may evade recognition or elimination 
by the cellular component of the maternal immune 
response. In Chapter 1.2 it was noted that maternal 
transplantation immunity is not functionally expressed 
in the placenta, possibly because hormones produced by 
the foeto-placental unit are immuno-suppressive at the 
high concentrations that occur in the micro - environment 
of that organ . If this is the case, the expression of 
anti-viral cellular immunity may also be compromised in 
the placenta, and trophoblast may therefore be an 
immunologically "privileged" site for virus growth. 
This may provide an explanation for the apparent pre-
dilection of many infectious agents for placental 
tissue (Fox 1977}. The growth and persistence of both 
RRV and SFV in the trophoblast in the present study 
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certainly supports this suggestion. 
The role of the placenta as a possible barrier 
to the transfer of virus from the maternal circulation 
to the foetus is unclear. At least 1 to 2 days appears 
to be necessary after the initial establishment of 
infection within the placenta before foetal infection 
with RRV or SFV occurs. This is presumably the time 
required for viral growth through to the foetal 
circulation. It seems likely therefore that there is 
a certain threshold of virus concentration required 
within the placenta before foetal infection begins. 
These results support Fox (l9771 who noted that it is 
probable that the placenta is able to delay the passage 
of infection into the foetus by acting non-specifically 
as a physical barrier. However, in a number of foeto-
placental units in the present study, even though the 
placenta had an extremely high concentration of virus 7 
or more days after maternal inoculation, no evidence of 
infection could be found in the foetus. A similar 
situation of placental infection without foetal 
infection has been described in other diseases including 
human rubella (Alford et al. l964} and CMV infections 
(Hayes and Gibas 1971}, as well as in animal infections 
with LCMV (Mims 1968}, CMV (Johnson l969} and IBRV 
(Kendrick et al. 1971; Kendrick 1973}. Thus, mechanisms 
appear to exist in some foeto-placental units which 
either prevent virus from reaching the foetus from the 
placental foci, or render the foetus immune to infection. 
One non-specific mechanism with the potential to restrict 
but not necessarily inhibit virus growth through the 
placenta is interferon which, during a normal mouse 
pregnancy, progressively concentrates in placental 
tissue (Fowler et al. 1980}. This may explain the 
localised nature of the virus foci in the trophoblast 
with both RRV and SFV, although this could also be 
linked to the location and number of the susceptible 
target cells. Furthermore, Murasko and Blank (1980) 
have demonstrated that exogenous interferon can exert 
a trans-placental anti-viral effect in mice with a high 
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rate of spontaneous in vivo leukaemia virus production. 
Although it is therefore possible that interferon may 
he involved with either preventing virus growing through 
the placenta or inhibiting' the replication of virus 
after reaching the foetus, it is difficult to understand 
why this or any other mechanism could be functional in 
some but not other foeto-placental units. 
It seems unlikely that these apparently unin-
fected foetuses with high concentrations of virus within 
their placental tissue have recovered from infection 
because: 
al as noted above, maternal IgG, which does cross 
to the foetus, may only exert an anti-viral 
effect in the foetus and placenta after 13 
days p.i.; 
b) the mouse foetus appears to be immunologically 
incompetent (Silverstein 1972), and the full 
development of the mouse immune response may 
only be completed after birth (Makinodan 
and Petersen 1962; Dalmasso et al. 1963; 
Chiscon and Golub 19721. Furthermore, 
both RRV and SFV are uniformly lethal for 
neonatal mice, even in doses of 100 pfu 
or less-
c) there was no evidence of in utero growth 
retardation in the form of lower body 
weight in the foetuses that were spared 
from an infection with RRV. 
In contrast to RRV infection, SFV invariably 
caused abortion in mice infected at gestation days 10 
or 11. Result s presented in this and the preceding 
Chapter indicate that the time of abortion induced by 
infection with SFV and the time of onset of the T-cell 
mediated anti-viral immune response coincide. Because 
the T-cell mediated immune response can cause tissue 
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destruction that may even prove fatal if there is a 
massive synchronous destruction of functionally 
important cells (Berger and Blanden 1981; Doherty and 
Bennink 1981), mothers inf~cted with SFV were immuno-
suppressed to investigate whether the abortion could 
be attributed to immuno-pathological mechanisms. 
Possibly the best way to induce maternal immuno-
suppression without using irradiation or anti-mitotic 
agents which may have a deleterious effect on the 
pregnancy is to use ATS. ATS has been shown to depress 
the primary cellular response to a number of viral 
agents, and appears to act against recirculating thymus-
derived small lymphocytes which are either killed or 
opsonised, then cleared by the reticuloendothelial 
system in the li~er (Lance et al. 1973}. Thus, ATS 
treatment results in a lymphopenia along with a 
selective depletion of small lymphocytes from the para-
cortical areas of lymph nodes and the peri-arteriolar 
regions of splenic follicles (Taub 19691. Mims (1969) 
used ATS to investigate whether the maternal death and 
abortion induced by injection of LCMV into pregnant 
mice was immuno-pathological in nature. It was found 
that potent ATS administered repeatedly did, in fact, 
reduce the incidence of death and abortion, and the 
pregnancies proceeded to term. However, because the 
cellular infiltrates which may have been expected to 
accompany a significant local cellular immune response 
were not evident in the placenta, it was suggested that 
the abortion caused by LCMV infection was possibly 
secondary to a systemic physiological disturbance in 
the mother which was not compatible with the progression 
of the pregnancy. In the present study, T-cell 
proliferation responses to both viral antigen and Con A 
were markedly depressed in the spleen and PALN following 
ATS treatment (Table 4.3}. However, as previously noted 
by Lance et al. (1973) in similar circumstances, the anti-
viral antibody titre was unaffected. This depression of 
T-cell anti-viral responses appeared to have no effect 
on the occurrence or time of abortion, suggesting that 
the premature interruption of pregnancy following 
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infection with SFV was not T-cell mediated. It must 
be noted, however, that Mims (1969} demonstrated that 
the ability of ATS to prevent maternal death or 
abortion after LCMV infection in mice was proportional 
to the potency of the preparation, and it is therefore 
possible that a more potent ATS in the present study 
may have produced a different result. Against this, 
Taub (1969) noted that the potency of ATS was 
proportional to the degree of lymphocyte depletion from 
lymphoid tissue. The significant depression of both 
the spleen and lymph node responses after treatment in 
the present study suggests that the ATS preparation 
used was highly potent. 
Although T-cell depletion did not appear to 
have any noticeable effect on the time that abortion 
occurred after maternal infection with SFV, the results 
presented in Table 4.4 indicate that the in utero infec-
tion may have been more advanced in the ATS group. This 
suggests that the onset of the maternal viraemia, and 
therefore placental infection, was earlier and of 
greater magnitude in the absence of sensitised T-cells. 
The reason why the accelerated in utero infection 
associated with ATS treatment was not reflected as 
an early abortion is not clear. Perhaps with larger 
groups of mice and more frequent inspections of them 
following infection, a difference in the time of abortion 
following ATS treatment may have been apparent. 
Other clues as to the reason why abortion 
occurs following infection of 11-day pregnant mice with 
SFV comes from an examination of Figures 4.10 and 4.11. 
It appears that the outcome of SFV infection during 
pregnancy depends upon the timing of infection with 
regard to the stage of gestation. Infection with SFV 
at day 10 or day 11 of ges~ation always results in 
abortion, and this appears to be preceded by uniform 
foetal infection. However, infection with SFV earlier 
in gestation does not always result in abortion, and 
in those pregnancies which were not interrupted at 
least one uninfected foetus was detected. Thus, the 
outcome of SFV infection in this latter group of 
95 
mothers resembles that observed following infection of 
11-day pregnant mice with RRV (Figure 4.3}. These 
results indicate that the abortion caused by SFV is 
only precipitated by uniform foetal infection, and are 
in accord with Arthur (1975} who noted that in poly-
tocous animals, provided at least one viable foetus is 
present within a pregnancy, normal gestation and 
parturition will occur. It is presumed that the 
abortion caused by SFV is somehow linked to a 
perturbation in foeto-placental hormone production. 
The fact that abortion only occurs in some infected 
mothers suggests that it is not caused by adverse effects 
of the infection on maternal physiological function. 
Furthermore, although it is difficult to prove whether 
abortion could result from a virus-induced impairment 
of placental function, the high titres of SFV in all 
placentas of the 2 mice that did not abort following 
infection at day 7 (Figure 4.10) tend to indicate that 
this is not the case. Whatever the mechanism involved, 
the time interval between foetal infection and abortion 
is short and, according to Figure 4.7, may be only 12 
hours. 
As noted above, the pattern of foetal infection 
in the mice that do not abort following SFV inoculation 
is similar to that observed with RRV, in that each 
pregnancy contains some dead and some uninfected, live 
foetuses. This suggests that the mechanisms involved 
in determining which foetuses are infected and which are 
spared may be similar for both viruses. However, the 
results presented in Figures 4.9 and 4.11 suggest that 
SFV may be more efficient than RRV at causing foetal 
infection at most stages of gestation. In fact, at 
gestation days 10 or ll all foetuses seem to be fatally 
infected, with abortion occurring as a consequence. 
Thus, the reason why abortion was not observed with RRV 
may have been that the virus rarely caused uniform 
foetal infection. In the few cases where all foetuses 
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were found to be infected with RRV, there was a 
possibili ty that the animal may have aborted after the 
time of harvest. Nevertheless, Aaskov et al. (1981a) 
reported 1 abortion out of 150 pregnant mice infected 
with RRV, and it is of interest that virus was detected 
in all the aborted foetusei. 
The results presented by Aaskov et al. (198la) 
provide an interesting comparison with some of the 
results of the present study. They also infected 
pregnant CBA/H mice with the T48 strain of RRV, however 
they used older mice (10-l6 weeks of age)., a larger 
dose of virus (10 6 pfu)., and a different route of 
inoculation (i.v.).. Tne maJor differences between the 
2 studies are: 
a) although Aaskov et al. (1981a) noted that 
infection occurred in a proportion of 
foetuses in each pregnancy, some of these foet-
uses were thought to have recovered in utero; 
b) Aaskov et al. (1981a) detected foetal 
infection much earlier than in the present 
study, at 1 day p.i.; 
c) they did not observe consistent placental 
infection at any time after maternal infection 
at gestation day 10. In fact, on each of 
days 1 to 9 p.i. only 50% (approximately) 
of the placentas contained virus. 
Some of the differences between these two 
studies may be attributable to the different dosage and 
route of infection. A large i.v. dose of virus would 
create an immediate maternal viraemia facilitating early 
seeding of the virus to the placenta, and possibly the 
foetus. For this reason, the dosages used throughout 
the present study were chosen to be high enough to 
uniformly infect all animals but it was hoped that a 
viraemia would only result after virus replication. 
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The other disparities between the results of Aaskov 
et al. (1981a) and those of the present study may be 
due to a divergence of virulence and tropisms between 
virus stocks. Whereas the- T48 strain used in the 
present study was in its 13th mouse brain passage, 
that used by Aaskov et al. G98la} was in its 6th 
mouse carcass passage. 
In summation, infection of pregnant mice with 
eitherRRVor SFV can result in viral growth in both 
placental and foetal tissue which ultimately leads to 
foetal death. This large intrauterine viral antigen 
load may be responsible for the perturbation of the 
mothers' anti-viral immune response observed in the 
results of Chapter 3. The mechanisms involved in the 
pathogenesis of the in utero infections are, ·however, 
not clear. In particular, the reason why some foetuses 
are spared from infection whereas others within the 
same pregnancy succumb is puzzling, especially when 
it is considered that because the pregnancy is inbred 
the foetuses should all be genetically identical. 
This is investigated further in the next Chapter. 
CHAPTER 5 
THE NATURE OF THE MECHANISMS THAT DETERMINE 
WHICH FOETUSES ARE INFECTED AND WHICH ARE 
SPARED FOLLOWING MATERNAL INFECTION WITH EITHER 
ROSS RIVER VIRUS OR SEMLIKI FOREST VIRUS 
98 
99 
INTRODUCTION 
In the previous Chapter, virological aspects 
of the pathogenesis of in ~tero infections with RRV and 
SFV were described. The placenta, in particular, played 
a critical role in determining the outcome of infection. 
Foetal infection was aided by the apparent predilection 
of both viruses for placental trophoblast, and their 
subsequent growth and persistence at high titre in that 
organ. However, following maternal infection with either 
RRV or SFV at certain stages of gestation, a proportion 
of the foetuses in each pregnancy were always spared, 
even though others were infected and rapidly died. The 
sparing of one or more foetuses resulted in the 
continuation of the pregnancy rather than abortion. 
The experiments described in this Chapter 
were designed to determine whether some foetuses are 
spared because virus does not migrate from their 
placentas, or whether they are specifically protected 
from virus infection by an immunological process. 
RESULTS 
Are foetuses spared from in utero infection with RRV 
because they are protected against the infection? 
Foetuses spared from in utero infection with 
RRV were experimentally challenged with RRV after birth 
in order to assess their immune status. To avoid the 
influence of antibody-enriched colostrum and milk this 
challenge was performed on foetuses delivered by caesarian 
section and fostered onto uninfected mothers. 
Preliminary experiments (not presented) 
indicated that fostering was more successful if the 
caesarian sections were performed at gestation day 19, 
rather than day 18. Therefore, 3 11-day pregnant mice 
were infected i.p. with 2600 pfu of RRV, and 8 days 
100 
later their 6 living foetuses were removed by caesarian 
section and fostered onto 2 uninfected CBA/H mothers 
which had just given nirth. naturally. These, and a 
fostered control litter from a 19-day pregnant, 
uninfected mother, were challenged s.c. 24 hours later 
with lOO pfu of RRV. The results (Table 5.1) show that 
all control neonates died with a mean survival time of 
2.8 days, whereas all neonates delivered from infected 
mothers survived challenge. 
The duration of this protection was evaluated. 
Eleven-day pregnant mice were infected i.p. with 2600 pfu 
of RRV, and 8 days later their living foetuses were 
delivered by caesarian section and fostered onto 
uninfected mothers. Groups of these neonates and controls 
from uninfected mothers were infected i.p. with l3QO pfu 
of RRV at either l, 3, 6 or 9 days after fostering. 
Control neonates were susceptible to infection at all 
times, although the mean survival time increased with age 
(Table 5.2}. All neonates from infected mothers were 
resistant to infection at days l, 3 and 6 of life but not 
day 9, although the mean survival time of the latter group 
was 2.2 days longer than the control group. These results 
indicate that the foetuses that are spared from in utero 
infection with. RRV are specifically protected against the 
virus, but this protection is only short-lived. 
The nature of the protective mechanisms 
The transient nature of the foetal protection 
against RRV challenge suggested that it was mediated by 
antibody passively acquired from the mother. Serum from 
spared foetuses was therefore separated into its different 
inununoglobulin fractions to establish whether anti-RRV 
activity was present and, if so, what antibody classes 
were involved. 
A group of 8 11-day pregnant mice were infected 
i.p. with 2600 pfu of RRV, and 7 days later they were killed 
and their sera pooled. There were 28 dead and 41 live 
foetuses present. Serum was obtained from the live foetuses 
(hereafter termed infected foetal serum) by taking whole 
Table 5.1 
Mothers 
Infectedc 
Uninfectedd 
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The responses of foetusesa which survive maternal 
infection with RRV to post-natal challenge with 
homologous virus 
Number of Number Mean survival 
Challenged Surviving time (days) 
Neonates b Challenge 
6 6 -
5 0 2.8 
a Foetuses were delivered by caesarian section from either RRV-
infected or uninfected 19-day pregnant mothers and fostered 
onto uninfected mothers. 
b Fostered neonates were challenged s.c. with 100 pfu of RRV. 
c Mothers were infected i .p. with 2600 pfu of RRV at gestation 
day 11. 
d Uninfected control mothers. 
N 
0 
rl 
Table 5.2 The duration of protection against post-natal challenge 
with RRV in the foetusesa which survive maternal infectionb 
Time of challenge C Neonates from infected mother Neonates from uninfected mother 
( Day of 1 if e) Number Number M.S.T. d Number Number M.S.T. 
challenged survived (days) challenged survived (days) 
1 6 6 - 26 0 3.2 
3 3 3 - 3 0 3.3 
6 4 4 - 4 0 3.4 
~· 9 4 0 8.0 4 0 5.8 
a Foetuses were delivered by caesarian section from 19-day pregnant mice and fostered onto uninfected mothers. 
b Mothers were infected i.p. with 2600 pfu of RRV at gestation day 11. 
c All neonates which survived delivery were challenged i .p. with 1300 pfu of RRV at different times after birth. 
d M.S.T. = Mean Survival Time. 
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blood lapproximately 50 ul per foetus) into 2 ~l of 
saline and gently centrifuging to remove erythrocytes. 
A further 9 uninfected mothers and their 78 living foetuses 
were also bled at the same stage of gestation. The immuno-
... 
globulins present in these 4 pools, and in hyper-immune 
ascites fluid made against RRV as a known high-titred 
antiserum, were identified by the gel diffusion test 
(Figure 5.1, Table 5.31. In the foetal sera, IgM and 
IgA were not detectable, and only faint precipitin lines 
against IgG2b were observed. All 6 irmnunoglobulin isotypes 
were detected in the ascites fluid and the 2 maternal serum 
pools. It must be noted that more than 1 precipitin line 
was detected against anti-IgM and anti-IgA in Figure 5.1 
land Figure 6.1). This is presumably because these antisera 
contain contaminating specificities against other serum 
proteins. For example, antisera raised against IgM may 
contain contaminating specificities against a -macroglobulin 
(Ey 1973). 
All 4 serum pools, plus the ascites fluid were 
fractionated on a Sepharose CL-4B-protein A column. The 
amount of serum protein loaded onto the column was: 
ascites fluid, 121.5 mg; infected mother, 121.6 mg; 
infected foetus, 10.6 mg; control mother, 122.8 mg; 
control foetus, 28.2 mg. The optical density of each 
fraction in the Coomassie Blue reaction is presented in 
Figure 5. 2, and is proportional to the protein content. 
Because the elution pattern obtained with the hyper-
immune ascites fluid indicated that 4 major protein 
peaks were present, for each of the other serum pools 
the fractions in the vicinity of these peaks were pooled, 
concentrated, and the immunoglobulin subclasses identified 
(Table 5.3). In the ascites fluid all detectable IgA, 
and a proportion of the IgM, passed through the column 
without binding and eluted with the other serum 
constituents in peak 1. Some IgM appeared to bind to 
the column, being eluted with IgGl in peak 2, and 
IgG2a/IgG3 in peak 3. IgG2b was present in peak 4. 
The binding of a proportion of the IgM to the column 
was surprising, but has been reported previously by 
Field et al. (1980} . 
-..,,,,, 
-'l 
Figure 5.1 Gel diffusion test: The identity of the 
immunoglobulin isotypes present 1n non-
fractionated serum pools. 
All tests were set up as follows: 
Ascites fluid 
0 
Blank 0 Q Infected mothers' 
serum 
0 
Anti-immunoglobulin 
Control Infected 
foetuses' foetuses' 
serum 0 Q serum 
0 
Control mothers' 
serum 
Anti-immunoglobulins were: 
Test A= Anti-IgM 
Test B = Anti-IgA 
Test C = Anti-IgGl 
Test D = Anti-IgG2a 
Test E = Anti-IgG2b 
Test F = Anti-IgG3 

s:;j< 
0 
r-i 
Peak Fractionsb 
Number (Approx.) 
1 1 - 17 
2 20 - 40 
3 44 - 54 
4 'I' 57 on 
Non-fractionated 
serum 
Table 5.3 The i_dentity of jmmunoglobulins detected in 
various fractionsa of maternal and foetal sera 
and hyper-immune ascites fluid 
Antibody detectedc 
Ascites Infectedd 
fluid 
mother foetus 
A} M A, M -
M, Gl Gl -
M, G2a, G3 G2a, G3 G2a 
G2b G2b -
A, M, Gl, A, M, Gl Gl, G2a, 
G2a, G2b, G2a, G2b, G2b, G3 
G3 G3 
Control d 
mother foetus 
A, M -
Gl Gl 
G2a G2a 
- -
A, M, Gl, Gl, G2a, 
G2a, G2b, G2b, G3 
G3 
a Sera were fractionated on a Sepharose CL-4B-protein A column using a linear pH gradient. The elution patterns 
are displayed in Figure 5.2. 
b Peak sizes varied slightly between sera but always encompassed the relevant fractions. 
c In the gel diffusion test. Immunoglobulin class or subclass presented. 
d 11-day pregnant mice were infected i.p. with 2600 pfu of RRV. At 7 days p.i. they and their living foetuses 
were bled. Control sera were taken from uninfected mothers and their foetuses at the same stage of gestation. 
Fig_ure 5.2 
"'! 
Elution Qatterns obtained with various 
serum samples after fractionation on a 
Sepharose CL-4B-protein A column. 
11-day pregnant mice were infected i.p. with 2600 pfu 
of RRV. Serum was taken from the mothers and all 
living foetuses 7 days later. Control sera were from 
uninfected mothers and their foetuses at the same stage 
of gestation. The optical density of each fraction after 
treatment with Coomassie Blue is plotted, and is 
proportional to the _protein content. The approximate 
positions of the 4 major peaks detected in the ascites 
fluid are shown at the top of the figure. 
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A similar antibody distribution was observed 
in the peaks from the infected mother's serum, although 
IgM was not looked for in peaks 2 or 3. With the other 
3 serum pools, some isotypes initially detectable in the 
undiluted sera were not found in the fractionated peaks. 
This was probably because the peaks were not concentrated 
sufficiently to obtain a reaction in the relatively 
insensitive gel diffusion test. 
All peaks were tested for RRV-specific anti-
body (Table 5.4). No antibody activity was detected in 
the peaks from the control mothers or their foetuses. 
Antibody activity was detected in peaks 1, 3 and 4 
(corresponding to the IgM/IgA, IgG2a/IgG3, and IgG2b 
peaks) of infected mothers' serum, but only in peaks 3 
and 4 (corresponding to the IgG2a/IgG3, and IgG2b peaks) 
of the serum from their foetuses. Although the antibody 
titres from the infected motherswere high compared to 
their foetuses, approximately 12 times more maternal 
serum was processed through the column. 
As IgM was detected in maternal but not 
foetal serum, and as RRV-specific IgG was detected in 
both, it seemed that some foetuses were protected from 
in utero infection by the passive transfer of maternal 
IgG. The fate of an individual foetus might have depended 
on the timing of IgG transfer from the maternal circulation 
relative to the timing of migration of virus from the 
particular placenta. This was tested by allowing 
placental infection with RRV to become established, then 
giving the infected mother hyper-immune ascites fluid 2 
days before the expected time of onset of her own anti-
body response. 
Two groups of 5 11-day pregnant mice were 
infected i.p. with 2600 pfu of RRV. At 48 hours and 
72 hours p.i. they were given 0.2 ml i.p. of either hyper-
immune anti-RRV ascites fluid, or normal ascites fluid as 
a control. All mice were killed at 7 days p.i., the 
numbers of dead and live foetuses noted, and placentas 
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Table 5.4 HI antibody 1n peaks from infecteda and control 
mothers and their foetuses 
Peakb HI titrec 
Number 
Infected Control 
Mother Foetus Mother Foetus 
1 128 < 10 < 10 < 10 
2 < 2 < 2 < 2 < 2 
3 1024 32 < 2 < 2 
4 64 4 < 2 < 2 
Undilute 
NDd serum 256 < 2 < 2 
a 11-day pregnant mice were infected i.p. with 2600 pfu of 
RRV. At 7 days p.i. serum was obtained from them and 
their living foetuses. Control sera were taken from 
uninfected mothers and their foetuses at the same stage 
of gestation. 
b These peaks correspond to those 1n Figure 5.2 and Table 
5.3. 
c Reciprocal of the titre per ml. 
d ND= Not Done. 
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from each mother were pooled and assayed for virus 
[Table 5.51. In the mice given normal ascites fluid 
there were 20 live and l8 dead foetuses, compared with 
45 live and only 1 dead foetus in the group given immune 
ascites fluid. No virus was detected in the latter 
foetus so this death was probably non-specific. All 
placental pools contained virus at high titre. Thus, 
all foetal infection could be prevented using immune 
ascites fluid even though virus was present in high 
titre in placental tissue. 
The effect of infection with RRV during an outbred 
pregnancy 
Experiments described so far in this study 
have only investigated the effects of maternal virus 
infection in inbred pregnancies. As this type of 
mating does not occur naturally, the effect of 
infection with RRV during an outbred or allogeneic 
pregnancy was examined. 
Five CBA/H females pregnant to Balb/c males 
were infected i.p. with 2600 pfu of RRV at gestation day 
11, and killed 7 days later. Live and dead foetuses, as 
well as their placentas, were pooled from each mouse for 
virus assay. Two living foetuses were fostered onto an 
uninfected mother and challenged s.c. with 100 pfu of 
RRV 24 hours after caesarian section. 
There was no difference between the outcome 
of maternal infection in an outbred pregnancy compared 
to what has been described previously in the inbred 
CBA/H x CBA/H pregnancy. All dead foetal pools and 
placental pools contained virus at high titre (Table 5.6). 
The three pools of live foetuses had no detectable virus. 
Of the 2 fostered foetuses, .one died overnight from 
unknown causes, whereas the other was protected against 
post-natal challenge with RRV . 
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Table 5.5 The effect of normal and immune ascites fluids on 
in utero infection with RRVa 
Groupb 
Mouse Number of foetuses Pl acenta l virus 
number titre (log10 pfu/g) Live Dead 
Normal l 6 4 6.75 
ascites 2 6 1 6.58 fluid 
3 2 5 7. 76 
4 3 4 6.36 
5 3 4 6.60 
Immune 1 .10 0 6.18 
as cites 2 9 le 6.49 fluid 
3 10 0 6.79 
4 9 0 6.54 
5 7 0 5.39 
a 11-day pregnant mice were infected i .p. with 2600 pfu of RRV. 
b 0.2 ml of either normal or immune ascites fluid given 1.p. 
at 48 hours and 72 hours p.i. 
c No virus was detected in this foetus. 
1 0 9 
Table 5.6 The effect of infection with RRV during an out-
a bred pregnancy 
Living foetus Dead foetus Placental 
Mouse 
Titreb b Titre Number Number Titre 
1 1 < l. 7 6 7.60 
2 2 < 1. 7 6 6.90 
3 2c < 1 7 l. ' 3 5.48 
4 le NDd 5 7.79 
5 0 - 6 6.30 
a CBA/H females pregnant to Balb/c males were infected 
i.p. with 2600 pfu of RRV at gestation day 11, and 
killed 7 days later. 
b Virus titre (log10 pfu/g). 
c One foetus from each mouse was fostered onto an 
uninfected mother. Of the 2 foetuses, one died 
within 12 hours and the other survived > 8 days 
after s.c. challenge with 100 pfu of RRV. 
d ND= Not Done. 
6.70 
6.88 
6.78 
6.58 
6. 86 
b 
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The post-natal death rate following maternal infection 
with RRV_at gestation day 11 
Aaskov et al. (1981a) described a high post-
natal death rate in the young of mothers infected with 
RRV. This would not be predicted from the results of 
the present study because all foetuses that survive to 
parturition should be protected against virus infection. 
The incidence of post-natal deaths in neonates born 
naturally to mothers infected with RRV at gestation day 
11 was therefore examined. Because this entailed 
frequent handling of the babies, and consequent 
disturbance of the mother, a group of control mothers 
injected with saline was included. 
Two groups of 8 11-day pregnant mice were 
injected i.p. with either 0.1 ml of normal saline or 
2600 pfu of RRV. All mothers were individually caged 
and examined regularly for the number of live birt hs, 
still births and mummified foetuses. The times of any 
post-natal deaths were noted (Table 5.7). It must be 
emphasised that some of the totals, especially for the 
mummified foetuses and still births, may be lower than 
the actual number because of cannibalism by the mother. 
All available still births and post-natal deaths, but not 
mummified foetuses, were assayed for virus. 
There were 15 live births and 4 still births 
in the infected group, and 52 live births and 6 still 
births in the saline group. Virus was detected in 3 of 
of the 4 still births from the infected mothers. There 
appeared to be a higher rate of post-natal deaths in 
the infected group (6 deaths out of 15 live births= 
40%), compared to the saline group (9 deaths out of 
52 live births= 17%). 
The role of maternal antibody in the outcome of in utero 
infection with SFV 
Concentration was then focused on the role, 
r-1 
r-1 
r-1 
Table 5.7 The incidence of post-natal death following maternal inoculationa 
with either saline or RRV at gestation day 11 
Number observed at birth Number of post-natal deaths in the period (hr after birth) 
Groupa live still mummified 3-8 8-24 24-48 48-72 72-96 96-120 
births births foetuses 
Saline 52 6d 0 ld 6d 2d 0 0 0 
RRV-infected 15 4b 14d 3C 2C 0 0 0 le 
" 
a Groups of 8 11-day pregnant mice were injected i .p. with either 0.1 ml of normal saline or 2600 pfu of RRV. 
b Virus detected in 3 of the 4 still births. 
c No virus detected. 
d Not assayed for virus. 
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if any, of maternal antibody in the pathogenesis of 
in utero infection with SFV. Results presented earlier 
in this Chapter suggested that hyper-immune ascites fluid 
administered to pregnant mice after placental infection 
with RRV had established, but before the onset of the 
mother's antibody response, protected all foetuses from 
infection. A similar experiment was therefore performed 
with SFV. 
Two groups of 5 10-day pregnant mice were 
infected i.p. with 7000 pfu of SFV. At 48 hours and 
72 hours p.i. they were given 0.2 ml i.p. of either normal 
ascites fluid or immune anti-SFV ascites fluid. Of the 
mice given normal ascites fluid, all aborted between 
days 4 and 6 p.i. (Table 5.8). Only one abortion (at 
day 7 p.i.) was observed in the mice given immune ascites 
fluid. The mice that had not aborted were harvested at 
gestation day l9 (i.e., day 9 p.i.).. No dead foetuses 
were observed. Of 7 live foetuses which were success-
fully fostered onto uninfected mothers, all survived 
s.c. challenge with 7000 pfu of SFV. Of the 4 placental 
pools, 3 had detectable titres of virus. Presumably, the 
haematogenous spread of virus to the placenta was 
prevented in the mother that had no detectable placental 
virus, and did not abort (Immune ascites group, number 5). 
Thus, similar to the results obtained earlier 
with RRV, hyper-immune ascites fluid is capable of 
protecting foetuses against in utero infection with SFV, 
even though high titres of virus may be present in the 
placental tissue. When foetal protection occurs, 
abortion is not observed. 
DISCUSS IO~ 
One aim of the ihvestigations reported in 
this Chapter was to elucidate why some fo etuses died in 
utero whereas others were spared following maternal 
infection with RRV. Initial evidence indicated that 
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Table 5.8 The effects of normal and immune ascites fluids 
on in utero infection with SFVa 
b Mouse Number of foetuses Placental virus c Group number titre (log 10 pfu/g) Live Dead 
Normal 1 Aborted 4 days p. l • NDd 
ascites 2 II 5 II ND fluid 
3 II 5 II ND 
4 II 5 II ND 
5 II 6 II ND 
Immune 1 Aborted 7 days p. 1 . ND 
ascites 2 8 0 8.45 fluid 
3 8 0 6.30 
4 3 0 4 .15 
5 6 0 < l. 7 
a 11-day pregnant mice were infected i .p. with 7000 pfu of SFV. 
b 0.2 ml of either normal or immune ascites fluid given 1 .p. 
at 48 hours and 72 hours p.i. 
c Placental pools from all mice that had not aborted were 
assayed for virus content at 9 days p.i. 
d ND= Not Done. Aborted tissues were not available for 
virus assay. 
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these spared foetuses were protected against virus 
challenge. Two observations suggested that the 
protection was mediated by passively transferred 
maternal antibody rather than an active foetal immune 
response. Firstly, the offspring were only resistant to 
the lethal effects of homologous challenge for a short 
period after birth. The waning of protection between 
the 6th and 9th day of life (Table 5.2) may have been 
because the half-life of immunoglobulin in the mouse is 
between only 1.0 and 5.0 days (Fahey and Robinson 1963; 
Grey et al. 1971). Secondly, anti-RRV antibody activity 
was only observed in the IgG-containing peaks and was 
not associated with IgM or IgA. In the mouse, IgG is 
the only maternal antibody class transferred pre-natally 
to the foetus (Fahey and Barth 1965; Grey et al. 1971). 
If foetuses are spared from in utero infection 
with RRV because they have been passively immunised by 
specific maternal IgG, why do other foetuses within the 
pregnancy not get the benefit of this protection? The 
answer to this may be linked to the timing of foetal 
infection relative to the time of onset of specific 
maternal IgG production. The latter time is not known 
accurately but would be earlier than day 7 p.i. when 
strong anti-RRV activity was detectable in the maternal 
IgG2a/IgG3, and IgG2b peaks (Table 5.4). It seems likely 
that passive foetal immunisation would commence within 
6 hours of the release of specific IgG into maternal 
serum (Carretti and Ovary _1969). Foetal infection, on 
the other hand, probably occurred over a longer period. 
Although the time between in utero infection and death 
appears to be approximately 2 days (from Figure 4.3), 
live, infected foetuses were observed on days 3, 4, 5 and 
6, but not day 7 p.i. This suggests that foetal infection 
actively occurred from day 3 p.i. up to day 5 p.i. The 
reason why all foetuses did -not become infected at the 
same time may be because the concentration of virus in 
individual placentas varied considerably at each harvest 
time (Figure 4.2), indicating that either the time of 
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initial trophoblast infection, or the rate of growth of 
virus through the placenta was not uniform for each foetus. 
Because the onset of passive foetal immunisation may have 
coincided with the time of -active foetal infection, it is 
possible that the fate of each foetus depended on whether 
protective IgG or virus crossed the placenta first. Thus 
foetuses whose placental tissue had a high concentration 
of virus may have been more likely to be infected before 
the onset of transfer of passive protection, whereas 
others, with lower placental virus loads, may have been 
protected before virus was able to grow through the 
placenta. The observation that there was little or no 
difference in virus concentration in the placentas of 
dead foetuses compared to those of live foetuses at days 
5 to 7 p.i. (Figure 4.2) may be irrelevant to this 
discussion because whether or not a foetus will be 
protected or infected in utero has probably been 
determined by then. 
The results presented in Table 5.5 provide 
support for this hypothesis. The effect of passive 
immunisation against RRV earlier than would usually 
occur was to protect all foetuses from infection 
despite the continued presence of virus at high titre in 
the placenta. Thus, at least in this experimental 
system, passive therapeutic immuno-therapy appeared to 
be highly effective for foetal protection, providing it 
was performed soon after maternal infection. 
An attempt to further substantiate this 
hypothesis involved an investigation of the effect of 
RRV infection in 11-day pregnant, congenitally athymic 
nude CBA/H mice. Because these mice are T-cell 
deficient, they form IgM but not IgG in response to a 
viral infection (Bradish et al. 1979). In theory, 
therefore, all foetuses should be infected with RRV 
in utero because passive imm.unisation could not occur. 
However, this experiment was not completed. A major 
problem was related to the low fertility of nude mice 
which made it impossible to achieve a successful 
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pregnancy using an economically viable number of mice. 
The role of the protective maternal IgG in 
foetal tissue is unclear. Sissons and Oldstone (1980) 
noted that antibody plays an important role in the 
termination of a primary viral infection by the neutral-
isation of free virus particles and the lysis of infected 
cells before the release of progeny virus. In the 
present study, although maternal IgG presumably 
conferred protection by neutralising all virus moving 
fromtheplacental foci into the foetal circulation, 
antibody alone did not appear to be able to mediate 
recovery from in utero infection. Indeed, it seemed 
probable that once infection had established in the 
foetus, death was inevitable. The inability of 
maternal IgG to clear infection from foetal or placental 
tissue indicates that intra-cellular virus is not 
eliminated 1 and that the spread of virus probably occurs 
between contiguous cells. It therefore seems that the 
conclusion drawn in Chapter 4, that maternal IgG is able 
to neutralise virus in placental or foetal tissue, but 
only after a minimum of 13 days p.i. is incorrect. The 
reasons for the decrease in virus titres in these 
tissues after infection with RRV or SFV at gestation day 
5 and harvest 13 days later (Figures 4.8, 4.9, 4.10 .and 
4.11) are not known but may include autolysis, or a 
decrease with time, in the number of susceptible 
target cells. 
Of relevance to this discussion is the 
postulate of Bell and Billington (19801 that, in the 
mouse, complement-fixing, cytotoxic IgG2a production may 
be suppressed during pregnancy in favour of the 
production of non-complement-fixing IgGl. This was 
considered to be beneficial for the survival of the 
allogeneic foetus, especially because the IgGl was 
thought to be responsible for immunological enhancement 
117 
of foetal antigens. The results of the present study, 
however, suggest that, at least in viral infections 
during pregnancy, this may not be the case because anti-
RRV antibody activity was not detected in the IgGl peak 
of maternal serum (Table 5.4). Thus, even though the 
foetal mouse produces at least some of the complement 
components (Tachibana and Rosenberg 1966), it appears that 
either complement mediated antibody cytotoxicity does not 
occur in the infected foetus or placenta, or it is not 
an important mechanism for the clearance of virus from 
infected tissue. 
Aaskov et al. (l98la) noted that infection of 
pregnant mice with RRV was associated with a high post-
natal death rate in the offspring. Virus was not isolated 
from the dead infants, although in approximately 20% 
viral antigen could be demonstrated in cells lining the 
aqueduct of Sylvius and the choroid plexus. Similar 
results were observed in the present study, although 
immuno-fluorescence studies were not performed. RRV was 
not expected to cause either still births or post-natal 
deaths following maternal infection at gestation day 11 
because by gestation day 18 (i.e., day 7 p.i.) active 
foetal infection has ceased (Figure 4.3}. All uninfected 
foetuses at that time were, presumably, passively 
immunised against infection. The still births associated 
with RRV infection may have occurred because of the 
apparent inability of maternal IgG to mediate recovery 
from established foetal infection. If, occasionally, 
foetal infection established just prior to the transfer 
of maternal IgG, a slower spread of virus through the 
foetal tissues may have resulted. Thus, although death 
of the foetus may have been inevitable, its survival may 
have been prolonged until parturition. It is difficult 
to attribute the enhanced post-natal death rate to the 
direct effect of virus replication because RRV could 
not be isolated from these neonates. Any adverse effect 
of the infection in the mother involving, for example, a 
reduced milk supply, may also have contributed to a 
failure of the neonates to thrive. 
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The observation that foetal infection with 
SFV could be blocked by the administration of specific 
immune ascites fluid to pre-infected mothers (Table 5.8) 
suggests that the outcome of this infection during 
pregnancy may be dependent on mechanisms similar to 
those proposed for RRV. Abortion may occur when virus 
migrates into all foetuses within a pregnancy before 
passive immunisation commences. This is in accordance 
with the conclusion made in Chapter 4 that the essential 
difference between the outcome of maternal infection with 
RRV and SFV may be related to an apparent greater 
efficiency of SFV in growing through the placenta into the 
foetal circulation. The fact that the immune ascites 
fluid prevented abortion but not placental infection in 
3 animals also supports the proposal from Chapter 4 that 
abortion occurs as a consequence of foetal infection 
rather than any virus-induced impairment of placental 
or maternal function. 
If the outcome of both in utero infections is 
dependent on the timing of virus growth through the 
placenta relative to the time of passive antibody trans-
fer to the foetus, why is SFV more efficient at causing 
foetal infection than RRV? Because both viruses appear 
to require a similar time after maternal inoculation 
before foetal infection commences (Figures 4.3 and 4.7), 
the answer to this problem must be that effective foetal 
immunisation against SFV takes a longer time to achieve 
than against RRV. One possible reason for this is that 
although specific maternal IgG may be produced at the 
same time against each virus, the extensive areas of 
infected cells in the labrynth observed following SFV, 
but not RRV, infection (see Chapter 4) may adsorb the 
anti-viral antibody from the foetal circulation. 
The results of this study indicate that the 
outcome of in utero infection with RRV or SFV depended 
on the timing of maternal inoculation with regard to 
the stage of gestation (Figures 4.9 and 4 . 11). Although 
this has been observed in other infections, it is 
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usually because either the foetus gains immuno-competence 
during later gestation, or the specific target cells or 
organs in the foetus may only be present or susceptible 
for a brief period of time1Kilham et al. 1967; Osburn 
et al. 1971a, 1971b; Parsonson et al. 1977). In the 
present study, however, the fact that neonatal mice are 
uniformly killed by both strains of virus suggests that 
foetal mice may be highly susceptible to infection 
throughout the pregnancy. It is possible that the 
observed variation in severity of the in utero infections 
may be more a function of placental development~ In the 
mouse, blastocyst implantation occurs at 4.5 days after 
conception, and is complete at gestation day 6 (Rugh 1968). 
Perhaps the viruses are not able to grow through the 
immature placenta as efficiently as the day 10 or day 11 
placenta? If so, this would allow more time for passive 
immunisation of the foetus to occur. 
In conclusion, it appears that the pathogenesis 
and outcome of in utero infections of mice with RRV and 
SFV are dependent on similar mechanisms, which probably 
occur in both syngeneic and allogeneic pregnancies. The 
outcome of maternal infection with either virus appears 
to depend, in effect, on a "race" between protective 
maternal IgG and the virus for the foetus. When the 
antibody "wins", the foetus is protected, but when virus 
reaches the foetus first, death ensues. Because high 
titres of virus are present in each placenta it seems 
likely, but could not be proved, that virus will 
eventually cross into every foetus. It would therefore 
be of interest to examine the post-natal immune 
reactivity of the spared foetuses to see whether immune 
tolerance to the specific virus resulted. 
The concept of the placenta as a total 
barrier to the passage of virus to the foetus, at least 
with the infections in the present study, does not 
appear to be viable. Nevertheless, the ability of the 
placenta to delay the passage of RRV to the foetus by 1 
or 2 days is of vital importance to the pregnancy in 
that it allows sufficient time for the passive 
120 
immunisation of those foetuses not already infected. 
This is not the case with SFV, because, for unknown 
reasons, adequate immunisation of the foetus appears to 
take longer than with RRV. ~ These results support Fox 
(1977) who suggested that any resistance offered by the 
placenta to the passage of virus to the foetus is not 
absolute but only delaying, and is largely due to it 
acting in a non-specific fashion as a physical barrier. 
CHAPTER 6 
THE ROLE OF COLOSTRUM AND MILK IN 
PROTECTION OF THE NEONATAL MOUSE 
AGAINST PERIPHERAL INFECTION WITH 
ROSS RIVER VIRUS. 
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INTRODUCTION 
The results in Chapter 5 indicate that 
.. 
passively acquired maternal antibody may protect a 
proportion of foetuses within a pregnancy from in utero 
infection with RRV. The mechanisms involved in the pre-
natal antibody transfer were highly selective for the 4 
maternal IgG subclasses. rt was considered that the 
timing of antibody transfer from the mother relative to 
the time of virus growth through the placenta was of 
critical importance and determined whether or not a 
particular foetus was spared. As was indicated in 
Chapter 1.3, however, maternal antibody passively 
acquired pre-natally may not be as important as that 
acquired post-natally for the protection of the mouse 
neonate against infection. The experiments described 
in this Chapter were therefore designed to examine 
whether colostrum and milk from an immune mouse could 
protect susceptible neonates against peripheral 
challenge with RRV. 
RESULTS 
Does colostrum and milk from an immune mother protect 
a neonatal mouse against i.p. infection with RRV? 
To assess the ability of colostrum and milk 
from an immune mother to protect a neonate against RRV 
infection, it was necessary to ensure that any antibody 
acquired by the neonate before birth did not influence 
its immune status. Thus, newborn mice from uninfected 
mothers were fostered onto post-parturient mothers that 
had been infected i.p. with 2600 pfu of RRV at gestation 
day 11. Ten control neonates, suckling on their own 
uninfected mothers, and 10 of the neonates fostered 
onto immune mothers, were challenged i . p. with 1000 pfu 
of RRV 9 days after birth. The results (Table 6.1) show 
that immunity against challenge was conferred b y 
suckling on the immune mother. 
Table 6.1 The effect of the ingestion of immune colostrum 
and milk on the susceptibility of neonatesa to 
1 .p. infection with RRV 
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Mothers b Number of Number Mean survival 
challenged surviving challenge time (days) 
neonatesC 
Immune 10 10 -
Non-immune 10 0 6.2 
a All neonates were from uninfected mothers. 
b Immune mothers had been infected i .p. with 2600 pfu of RRV 
at gestation day 11. Neonates were fostered immediately 
after parturition. 
c All neonates were challenged 1 .p. with 1000 pfu of RRV 
at the 9th day of life. 
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The nature of the protection 
An experiment was designed to examine whether 
protective antibody was present in the serum of the 
neonates suckling on immune mothers and, if so, which 
antibody classes could be detected. 
A group of 30 neonates from uninfected mothers 
were fostered onto 5 post-parturient mothers that had 
been infected i.p. with 260Q pfu of RRV at gestation 
day 11. Nine days after fostering,both groups were 
killed and their serum pooled. Serum pools from 5 
uninfected mothers and their 32 neonates at 9 days of 
age were used as controls. The immunoglobulins present 
in these 4 pools, and in hyper-immune ascites fluid made 
against RRV as a known high-titred antiserum,were iden-
tified by the gel diffusion test (Figure 6.1, Table 6.2). 
All 6 immunoglobulin isotypes were detected in the 
ascites fluid and the 2 maternal serum pools. In the neo-
natal sera, IgM and IgA were not detectable, with 
precipitin lines only being observed for the IgG 
subclasses. 
All 4 serum pools were fractionated on a 
Sepharose CL-4B-protein A column. The amount of serum 
protein loaded onto the column was: 71.7 mg of immune 
mothers' serumi 89.6 mg of control mothers' serum; 42.2 mg 
of fostered neonates' serum; and 82.9 mg of control 
neonates' serum. The optical density of each fraction 
in the Coomassie Blue reaction is presented in Figure 6.2, 
and is proportional to the protein content. Because the 
elution pattern obtained with the hyper-immune ascites 
fluid (Figure 5.2) indicated that 4 maJor protein peaks 
were present, for each of the other serum pools the 
fractions in the vicinity of these peaks were pooled, 
concentrated, 2nd the immunoglobulin subclasses 
identified (Table 6.2). The locations of the different 
immunoglobulinswere: peak l, IgA and IgM; peak 2, IgGl; 
peak 3, IgG2a and IgG3; peak 4, IgG2b. All isotypes 
detected in the non-fractionated serum pools were also 
Figure 6.1 Gel diffusion test: The identity of the 
immunoglobulin isotypes present 1n non-
fractionated serum pools 
All tests were set up as follows: 
As.cites fluid 
0 
Blank 0 0 Immune mothers 1 
0 serum 
Anti-immunoglobulin 
Fostered Control 
neonates' neonates I 
serum 0 0 serum 
0 
Control mothers' 
serum 
Anti-immunoglobulins were: 
Test A= Anti-IgM 
Test B = Anti-IgA 
Test C = Anti-IgGl 
Test D = Anti-IgG2a 
Test E = Anti-IgG2b 
Test F = Anti-IgG3 

L.{) 
N 
r-f 
Peak 
Number 
1 
2 
3 
4 
1· 
Non-fractionated 
serum 
Fractionsb 
(approx.) 
1 - 17 
20 - 40 
44 - 54 
57 on 
Table 6.2 The identitt of immunoglobulins detected jQ 
various fractionsa of maternal and neonatal sera 
Ascites 
fluid 
A, M 
M, Gl 
M, G2a, G3 
G2b 
A, M, Gl, 
G2a, G2b, 
G3 
Antibody detectedc 
Immuned Fosterede 
Mother neonate 
A, M 
Gl 
G2a, G3 
G2b 
A, M, Gl, 
G2a, G2b, 
G3 
Gl 
G2a, G3 
G2b 
Gl, G2a, 
G2b, G3 
Controlf 
mother 
A, M 
Gl 
G2a, G3 
G2b 
A, M, Gl, 
G2a, G2b, 
G3 
Controlf 
neonate 
Gl 
G2a, G3 
G2b 
Gl, G2a, 
G2b, G3 
a Sera were fractionated on a Sepharose CL-4B-protein A column using a linear pH gradient. The elution pattern for 
the Ascites fluid is presented in Figure 5.2, and the patterns for the other serum pools are presented in Figure 6.2 
b Peak sizes varied slightly between sera but always encompassed the relevant fractions. 
c In the gel diffusion test, Immunoglobulin class or subclass presented. 
d Mothers were immunised by i.p. chal ·lenge with 2600 pfu of RRV at gestation day 11. 
e Neonates from uninfected mothers were fostered onto post-parturient immune mothers. Serum was taken from the 
mothers and their neonates 9 days after birth. 
f Control sera were from uninfected mothers and their neonates taken 9 days after birth. 
Figure 6.2 Elution patterns obtained with 
various serum samples after 
fractionation on a Sepharose 
CL-4B-protein A column. 
Newborn mice from uninfected mothers were fostered 
onto mothers that had been infected i.p. with 2600 
pfu of RRV at gestation day 11, and had just given 
birth. Controls were uninfected mothers and their 
neonates. Serum samples were taken from mothers 
and neonates 9 days after birth. The optical 
density of each fraction after treatment with 
Coomassie Blue is plotted, and is proportional 
to the protein content. The approximate positions 
of the 4 major peaks detected in the hyper-immune 
fluid (presented in Figure 5.1) are shown at the 
top of the figure. 
1 II 2 11 3 4 
0.5 control mother 
0.4 
0.3 
0.2 
0.1 
•••• 
0.5 infected mother 
-
0.4 
E 0.3 C 
0 
M 0.2 
-0 
-
>- 0.1 
."t:: 
V') 
C 
(1) 
control neonate 
-0 0.5 
0 0.4 u 
-Q_ 0.3 0 
0.2 
0.1 
0.5 fostered neonate 
0.4 
0.3 
0.2 
0.1 
fraction number 10 20 30 40 50 60 70 
pH 8.0 7.0 6.0 5.0 4.0 3.0 
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detected in the fractionated peaks. 
All serum pools and peaks were tested in the 
-HI test for the presence of RRV-specific antibody 
activity (Table 6.3}. No anti-RRV activity was detected 
in the control serum pools. The titres in the non-
fractionated serum pools from the immune mothers and 
their fostered neonates indicate that serum antibody 
levels comparable to the mothers were obtained by the 
neonatesafter only 9 days of suckling. Antibody activity 
was detected in all peaks of the immune mothers' serum 
although mainly in the IgG2a/IgG3 and IgG2b peaks. In 
the serum obtained from the neonates fostered onto immune 
mothers, antibody activity was not observed in the IgM/IgA 
peak, and was predominantly in the IgG2a/IgG3 peak. The 
absence of IgM in the fostered neonates' serum suggests 
that the protection was not due to an active immune 
response, and that the anti-RRV IgG was therefore 
maternal in origin. 
DISCUSSION 
The results of the present Chapter indicate 
that neonatal mice from non-immune mothers may be 
passively protected against a viral infection by 
colostrum and milk from an immune mother. Similar to 
the results of Chapter 5 where the pre-natal transmission 
of antibody to the foetal mouse was investigated, the 
protection correlated with the presence of all 4 maternal 
IgG subclasses in the offsprings' serum. This is in 
accord with the results of Guyer et al. (1976), who 
demonstrated receptors for the Fe end of IgG in the 
neonatal mouse gut. Although IgA and IgM are present in 
mouse colostrum (Guyer et al. 1976}, in the present study 
they were not absorbed by the neonate in detectable 
quantities. This agrees with Fahey and Barth (1965) 
and Iida et al. (1973), and suggests that the major role 
of colostral IgA and IgM is in defense of the neonate 
against enteric pathogens. 
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Table 6.3 HI antibody in peaksa from immune and control 
mothersb and their neonates 
Peak HI titre C 
Number 
Fosteredd Immune Control 
mother neonate 
Mother Neonate 
1 10 < 10 < 10 < 10 
2 2 32 < 2 < 2 
3 256 2048 < 2 < 2 
4 128 8 < 2 < 2 
Non-fractionated 
serum 640 1280 < 10 < 10 
a Peaks correspond to those in Figure 6.2 and Table 6.2 
b Mothers were immunised by i .p. challenge with 2600 pfu of RRV 
at gestation day 11. Control mothers were uninfected. 
c Reciprocal of the HI titre per ml. 
d Neonatal mice from uninfected mothers were fostered onto 
post-parturient immune mothers. Serum was taken 9 days 
after fostering. 
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The duration of the immunity conferred on the 
neonate post-natally could not be established because 
mice become resistant to the lethal effects of RRV 
~ 
infection at approximately 3 weeks of age. Nevertheless, 
the observation that, in the 1nouse, antibody can be 
absorbed from milk for up to 17 days after birth 
(Hemmings and Morris 19591, suggests that the post-natal 
acquisition of passive immunity may have provided a 
longer term protection against RRV infection than that 
acquired in utero. 
There was a marked difference between the 
relative concentrations of the IgG subclasses in neo-
natal serum compared to maternal serum (Table 6.3). 
This may be because the affinity of the intestinal 
receptors for IgG in the neonatal mouse varies for each 
subclass, with the highes·t affinity being observed 
for IgG2a and IgGl (Guyer et al. 1976). Unfortunately, 
the relative contributions of IgG2a and IgG3 to the 
total neonatal serum antibody could not be differentiated 
using the Sepharose-protein A column. Nevertheless, the 
observations of Guyer et al. (i976) that IgG2a is the 
major maternal serum IgG subclass in the mouse 1 and that 
IgG3 is, at least in the absence of infection, only 
present in trace amounts in colostrum, suggests that 
IgG2a is probably the predominant antibody in the 
IgG2a/IgG3 peak. 
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CHAPTER 7 
GENERAL DISCUSSION 
1: 
Ii 
I 
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Infections which influence the establishment 
and continuation of a healthy pregnancy, and the 
subsequent well-being of the young, are of considerable 
interest and importance in both human and veterinary 
medicine. In human medicine the social and humanitarian 
consequences of these infections have received greatest 
consideration whilst in veterinary medicine the effects 
on animal productivity and economics are the most 
important features. However, although the consequences 
of infection may be important in man and animals for 
different reasons, an understanding of pathological 
processes in one species is frequently of importance in 
solving similar problems in another (Coid 1977). There-
fore, in the present study, rather than attempting to 
obtain information about a specific pathogen of 
importance to either human or veterinary medicine, it 
was decided to establish a laboratory model to try to 
obtain a more general idea of the mechanisms which may 
occur in in utero virus infections. The laboratory 
mouse was chosen as the model because of its ease of 
breeding, storage and handling, the availability of 
large numbers of mice of different inbred strains, its 
short gestation period, and the ability to obtain 
pregnant mice at specified times of gestation. Because 
experiments using pregnant animals can take considerably 
more time than those with non-pregnant animals, in that 
once an adequate number have been mated they might not 
be used until days or weeks later, it was considered 
that the use of the mouse provided an opportunity to 
perform more intensive investigations than larger animals. 
Indeed, the mouse has been used as a model of numerous 
viral infections during pregnancy , some of which include 
reovirus type 2 (Hashirni et al. 1966); CMV (Johnson 1969); 
St. Louis encephalitis virus (Anderson and Hanson 1970); 
coxsackievirus BJ (Lansdown· and Coid l974; Lansdown 1975); 
polyoma virus (Mccance and Mims 1977); Ross River virus, 
getah and Murray Valley encephalitis virus (Aaskov et al. 
1981a); and Japane se encephalitis virus (Math ur et al. 19 81). 
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Whilst the size, gestation period , type of 
placentation, physiology and - endocrinology of the mouse 
differs from other species, there are some points raised 
in the present study that may be applicable to in utero 
infections in general. 
emphasize 2 of these. 
In particular, I would like to 
Firstly, the hypothesis that the 
outcome of in utero infection in the mouse depends on 
the relative timing of virus growth through the placenta 
with regard to the timing of the transfer of passive 
immunity from the mother may be applicable to all 
species that have a significant pre-natal transfer of 
antibody to the foetus. In fact, cases of placental 
infection without foetal infection would be more logically 
explained by this hypothesis than the concept of the 
placenta acting as a total barrier to the passage of 
virus to the foetus. This is especially so in light of 
the observation that virus is able to persist in the 
trophoblast in the face of a maternal immune response. 
Thus, the isolation of virus from placental tissue but 
not the foetus in human infections with rubella (Alford 
et al. 19641 and CMV (Hayes and Gibas 197l) could be 
because the foetuses were passively immunised before 
virus was able to grow· through the placenta. It is of 
interest that Cooper et al. (1969), reporting on the 
unpredictability of in utero infections, cited a case 
of non-identical twins whose mother had rubella during 
pregnancy, where only one child displayed the congenital 
syndrome. It is tempting to speculate that, similar to 
the situation with in utero infections with RRV in the 
present study, specific maternal IgG was transferred 
to the spared foetus in time to be protective but was 
too late to prevent infection in the other. 
The second point concerns the expression of 
maternal immunity in the foeto-placental unit. The 
results of the present study indicate that virus present 
in placental tissue is not eliminated by the maternal 
cellular or humoral immune responses. This suggests 
that viral antigen (in association with MHC antigens) 
is either blocked, not expressed, or not recognized. 
II 
11 
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This could be because the infected trophoblast observed 
within the body of the placenta is not accessible to 
the maternal leukocytes . It is also possible that the 
expression of the immune response is suppressed in the 
micro-environment of the placenta. If this latter is 
the case, the mechanisms involved in the immune 
suppression may be linked to one of the fundamental 
questions of reproductive and transplantation biology -
why is a foetus which displays paternal alloantigens 
not rejected by the mother? Therefore, investigations 
as to whether anti - viral cellular immunity is 
functionally expressed against infected trophoblast 
may provide another avenue for the elucidation of this 
problem . 
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